39 results on '"Roselli, P."'
Search Results
2. The new Italian seismic hazard model (MPS19)
- Author
-
Meletti, C., Marzocchi, W., D'amico, V., Lanzano, G., Luzi, L., Martinelli, F., Pace, B., Rovida, A., Taroni, M., Visini, F., Akinci, A., Anzidei, M., Avallone, A., Azzaro, R., Barani, S., Barberi, G., Barreca, G., Basili, R., Bird, P., Bonini, M., Burrato, P., Busetti, M., Camassi, R., Carafa, M., Cavaliere, A., Cecere, G., Cheloni, D., Chioccarelli, E., Console, R., Corti, G., D'agostino, N., Cin, M., D'ambrosio, C., D’amico, M., D’amico, S., Devoti, R., Esposito, A., Faenza, L., Falcone, G., Felicetta, C., Fracassi, U., Franco, L., Galvani, A., Gasperini, P., Gee, R., Capera, A., Iervolino, I., Kastelic, V., Lai, C., Locati, M., Lolli, B., Maesano, F., Marchesini, A., Mariucci, M., Martelli, L., Massa, M., Metois, M., Monaco, C., Montone, P., Moschetti, M., Murru, M., Pacor, F., Pagani, M., Pasolini, C., Peresan, A., Peruzza, L., Pietrantonio, G., Poli, M., Pondrelli, S., Puglia, R., Rebez, A., Riguzzi, F., Roselli, P., Rotondi, R., Russo, E., Sani, F., Santulin, M., Selvaggi, G., Scafidi, D., Selva, J., Sepe, V., Serpelloni, E., Slejko, D., Spallarossa, D., Stallone, A., Tamaro, A., Tarabusi, G., Tiberti, M., Tuvè, T., Valensise, G., Vallone, R., Vannoli, P., Vannucci, G., Varini, E., Zanferrari, A., Zuccolo, E., Danciu, L., Schorlemmer, D., Bazzurro, P., Giardini, D., Modena, C., Mulargia, F., Seno, S., Group, T., Meletti, C., Marzocchi, W., D'Amico, V., Lanzano, G., Luzi, L., Martinelli, F., Pace, B., Rovida, A., Taroni, M., Visini, F., Selva, Jacopo, Meletti C., Marzocchi W., D'amico V., Lanzano G., Luzi L., Martinelli F., Pace B., Rovida A., Taroni M., Visini F., Akinci A., Anzidei M., Avallone A., Azzaro R., Barani S., Barberi G., Barreca G., Basili R., Bird P., Bonini M., Burrato P., Busetti M., Camassi R., Carafa M.M.C., Cavaliere A., Cecere G., Cheloni D., Chioccarelli E., Console R., Corti G., D'agostino N., Cin M.D., D'ambrosio C., D'amico M., D'amico S., Devoti R., Esposito A., Faenza L., Falcone G., Felicetta C., Fracassi U., Franco L., Galvani A., Gasperini P., Gee R., Capera A.A.G., Iervolino I., Kastelic V., Lai C.G., Locati M., Lolli B., Maesano F.E., Marchesini A., Mariucci M.T., Martelli L., Massa M., Metois M., Monaco C., Montone P., Moschetti M., Murru M., Pacor F., Pagani M., Pasolini C., Peresan A., Peruzza L., Pietrantonio G., Poli M.E., Pondrelli S., Puglia R., Rebez A., Riguzzi F., Roselli P., Rotondi R., Russo E., Sani F., Santulin M., Selvaggi G., Scafidi D., Selva J., Sepe V., Serpelloni E., Slejko D., Spallarossa D., Stallone A., Tamaro A., Tarabusi G., Tiberti M.M., Tuve T., Valensise G., Vallone R., Vannoli P., Vannucci G., Varini E., Zanferrari A., Zuccolo E., Danciu L., Schorlemmer D., Bazzurro P., Giardini D., Modena C., Mulargia F., Seno S., and MPS19 Working Group
- Subjects
Peak ground acceleration ,Epistemic uncertainty ,Computer science ,010502 geochemistry & geophysics ,computer.software_genre ,01 natural sciences ,Interpretation (model theory) ,Seismic hazard ,Set (abstract data type) ,Range (statistics) ,Earthquake hazard analysis -- Italy ,Ensemble modeling ,Uncertainty quantification ,Probabilistic framework ,0105 earth and related environmental sciences ,Structure (mathematical logic) ,Probabilistic methods ,Earthquake prediction ,Geophysics ,Ensemble learning (Machine learning) ,Probabilistic method ,Italy ,Probabilities -- Mathematical models ,Data mining ,computer - Abstract
We describe the main structure and outcomes of the new probabilistic seismic hazard model for Italy, MPS19 [Modello di Pericolosità Sismica, 2019]. Besides to outline the probabilistic framework adopted, the multitude of new data that have been made available after the preparation of the previous MPS04, and the set of earthquake rate and ground motion models used, we give particular emphasis to the main novelties of the modeling and the MPS19 outcomes. Specifically, we (i) introduce a novel approach to estimate and to visualize the epistemic uncertainty over the whole country; (ii) assign weights to each model components (earthquake rate and ground motion models) according to a quantitative testing phase and structured experts’ elicitation sessions; (iii) test (retrospectively) the MPS19 outcomes with the horizontal peak ground acceleration observed in the last decades, and the macroseismic intensities of the last centuries; (iv) introduce a pioneering approach to build MPS19_cluster, which accounts for the effect of earthquakes that have been removed by declustering. Finally, to make the interpretation of MPS19 outcomes easier for a wide range of possible stakeholders, we represent the final result also in terms of probability to exceed 0.15 g in 50 years., peer-reviewed
- Published
- 2021
- Full Text
- View/download PDF
3. Enteral versus intravenous approach for the sedation of critically ill patients: A randomized and controlled trial 11 Medical and Health Sciences 1103 Clinical Sciences
- Author
-
Mistraletti, G, Umbrello, M, Salini, S, Cadringher, P, Formenti, P, Chiumello, D, Villa, C, Russo, R, Francesconi, S, Valdambrini, F, Bellani, G, Palo, A, Riccardi, F, Ferretti, E, Festa, M, Gado, A, Taverna, M, Pinna, C, Barbiero, A, Ferrari, P, Iapichino, G, Spanu, P, Anania, S, Andrighi, E, Di Carlo, A, Martinetti, F, Barello, S, Noto, A, Capello, G, Sabatelli, B, Brenna, G, Astori, M, Placido, P, Gattinoni, L, Protti, A, Pagan, F, Berto, V, Roselli, P, Ronzoni, G, Beck, E, Gaiotto, M, Radrizzani, D, Ferla, L, Giudici, R, Merlini, L, Pesenti, A, La Bruna, A, Rezoagli, E, Lucchini, A, Braschi, A, Niebel, T, Selvini, M, Cortesi, S, Quaini, A, Iotti, G, Contri, E, Sacchi, A, Livigni, S, Naretto, G, Deprado, A, Venturi degli Espositi, V, Caironi, P, Radeschi, G, Odetto, L, Ferrero, D, Cognolato, S, Penso, R, Vacchelli, R, Cardellino, S, Bosco, E, Bresciani, A, Pozzo, I, Alessio, A, Clarindo Rodrigues, V, Biase, E, Vivaldi, N, Nava, A, Rambaldi, M, Ponzetta, F, Bavutti, L, Palacios, B, Bergonzini, G, Mistraletti, G, Umbrello, M, Salini, S, Cadringher, P, Formenti, P, Chiumello, D, Villa, C, Russo, R, Francesconi, S, Valdambrini, F, Bellani, G, Palo, A, Riccardi, F, Ferretti, E, Festa, M, Gado, A, Taverna, M, Pinna, C, Barbiero, A, Ferrari, P, Iapichino, G, Spanu, P, Anania, S, Andrighi, E, Di Carlo, A, Martinetti, F, Barello, S, Noto, A, Capello, G, Sabatelli, B, Brenna, G, Astori, M, Placido, P, Gattinoni, L, Protti, A, Pagan, F, Berto, V, Roselli, P, Ronzoni, G, Beck, E, Gaiotto, M, Radrizzani, D, Ferla, L, Giudici, R, Merlini, L, Pesenti, A, La Bruna, A, Rezoagli, E, Lucchini, A, Braschi, A, Niebel, T, Selvini, M, Cortesi, S, Quaini, A, Iotti, G, Contri, E, Sacchi, A, Livigni, S, Naretto, G, Deprado, A, Venturi degli Espositi, V, Caironi, P, Radeschi, G, Odetto, L, Ferrero, D, Cognolato, S, Penso, R, Vacchelli, R, Cardellino, S, Bosco, E, Bresciani, A, Pozzo, I, Alessio, A, Clarindo Rodrigues, V, Biase, E, Vivaldi, N, Nava, A, Rambaldi, M, Ponzetta, F, Bavutti, L, Palacios, B, and Bergonzini, G
- Subjects
Male ,Simplified Acute Physiology Score ,Patient care planning ,Intensive Care Unit ,Hypnotics and Sedative ,Middle Aged ,Enteral Nutrition ,Nursing education research ,Hydroxyzine ,Central Nervous System Depressant ,Critical Illne ,Anesthesia ,Female ,Single-Blind Method ,Poisson Distribution ,Antipruritic ,Deep Sedation ,MED/41 - ANESTESIOLOGIA ,Melatonin ,Aged ,Human - Abstract
Background: ICU patients must be kept conscious, calm, and cooperative even during the critical phases of illness. Enteral administration of sedative drugs might avoid over sedation, and would be as adequate as intravenous administration in patients who are awake, with fewer side effects and lower costs. This study compares two sedation strategies, for early achievement and maintenance of the target light sedation. Methods: This was a multicenter, single-blind, randomized and controlled trial carried out in 12 Italian ICUs, involving patients with expected mechanical ventilation duration > 72 h at ICU admission and predicted mortality > 12% (Simplified Acute Physiology Score II > 32 points) during the first 24 h on ICU. Patients were randomly assigned to receive intravenous (midazolam, propofol) or enteral (hydroxyzine, lorazepam, and melatonin) sedation. The primary outcome was percentage of work shifts with the patient having an observed Richmond Agitation-Sedation Scale (RASS) = target RASS ±1. Secondary outcomes were feasibility, delirium-free and coma-free days, costs of drugs, length of ICU and hospital stay, and ICU, hospital, and one-year mortality. Results: There were 348 patients enrolled. There were no differences in the primary outcome: enteral 89.8% (74.1-100), intravenous 94.4% (78-100), p = 0.20. Enteral-treated patients had more protocol violations: n = 81 (46.6%) vs 7 (4.2%), p < 0.01; more self-extubations: n = 14 (8.1%) vs 4 (2.4%), p = 0.03; a lighter sedative target (RASS = 0): 93% (71-100) vs 83% (61-100), p < 0.01; and lower total drug costs: 2.39 (0.75-9.78) vs 4.15 (1.20-20.19) €/day with mechanical ventilation (p = 0.01). Conclusions: Although enteral sedation of critically ill patients is cheaper and permits a lighter sedation target, it is not superior to intravenous sedation for reaching the RASS target. Trial registration: ClinicalTrials.gov, NCT01360346. Registered on 25 March 2011.
- Published
- 2019
4. Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma
- Author
-
Pecorelli A, Lenzi B, Gramenzi A, Garuti F, Farinati F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Cabibbo G, Felder M, Morisco F, Gasbarrini A, Baroni GS, Foschi FG, Biasini E, Masotto A, Virdone R, Bernardi M, Trevisani F, Bolondi L, Biselli M, Bucci L, Caraceni P, Cucchetti A, Domenicali M, Venerandi L, Giacomin A, Maddalo G, Pozzan C, Vani V, Poggio PD, Olmi S, Balsamo C, Vavassori E, Benvegnù L, Cappelli A, Golfieri R, Mosconi C, Renzulli M, Bosco G, Roselli P, Dell'Isola S, Ialungo AM, Bruzzone L, Picciotto A, Marenco S, Risso D, Sammito G, Savarino V, Cammà C, Maida M, Costantino A, Barcellona MR, Affronti A, Mega A, Rinninella E, Mismas V, Cappa FM, Dall'Aglio AC, Feletti V, Lanzi A, Neri E, Stefanini GF, Tamberi S, Missale G, Porro E, Guarino M, Gemini S, Schiadà L, for the Italian LiverCancer (ITA. LI. CA) group, Donatella Magalotti, Carla Serra, Pecorelli A, Lenzi B, Gramenzi A, Garuti F, Farinati F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Cabibbo G, Felder M, Morisco F, Gasbarrini A, Baroni GS, Foschi FG, Biasini E, Masotto A, Virdone R, Bernardi M, Trevisani F, Bolondi L, Biselli M, Bucci L, Caraceni P, Cucchetti A, Domenicali M, Magalotti D, Serra C, Venerandi L, Giacomin A, Maddalo G, Pozzan C, Vani V, Poggio PD, Olmi S, Balsamo C, Vavassori E, Benvegnù L, Cappelli A, Golfieri R, Mosconi C, Renzulli M, Bosco G, Roselli P, Dell'Isola S, Ialungo AM, Bruzzone L, Picciotto A, Marenco S, Risso D, Sammito G, Savarino V, Cammà C, Maida M, Costantino A, Barcellona MR, Affronti A, Mega A, Rinninella E, Mismas V, Cappa FM, Dall'Aglio AC, Feletti V, Lanzi A, Neri E, Stefanini GF, Tamberi S, Missale G, Porro E, Guarino M, Gemini S, Schiadà L, Pecorelli, A., Lenzi, B., Gramenzi, A., Garuti, F., Farinati, F., Giannini, E. G., Ciccarese, F., Piscaglia, F., Rapaccini, G. L., Di Marco, M., Caturelli, E., Zoli, M., Borzio, F., Sacco, R., Cabibbo, G., Felder, M., Morisco, F., Gasbarrini, A., Baroni, G. S., Foschi, F. G., Biasini, E., Masotto, A., Virdone, R., Bernardi, M., Trevisani, F., Bolondi, L., Biselli, M., Bucci, L., Caraceni, P., Cucchetti, A., Domenicali, M., Magalotti, D., Serra, C., Venerandi, L., Giacomin, A., Maddalo, G., Pozzan, C., Vani, V., Poggio, P. D., Olmi, S., Balsamo, C., Vavassori, E., Benvegnu, L., Cappelli, A., Golfieri, R., Mosconi, C., Renzulli, M., Bosco, G., Roselli, P., Dell'Isola, S., Ialungo, A. M., Bruzzone, L., Picciotto, A., Marenco, S., Risso, D., Sammito, G., Savarino, V., Camma, C., Maida, M., Costantino, A., Barcellona, M. R., Affronti, A., Mega, A., Rinninella, E., Mismas, V., Cappa, F. M., Dall'Aglio, A. C., Feletti, V., Lanzi, A., Neri, E., Stefanini, G. F., Tamberi, S., Missale, G., Porro, E., Guarino, M., Gemini, S., Schiada, L., Pecorelli, Anna, Lenzi, Barbara, Gramenzi, Annagiulia, Garuti, Francesca, Farinati, Fabio, Giannini, Edoardo G, Ciccarese, Francesca, Piscaglia, Fabio, Rapaccini, Gian Lodovico, Di Marco, Maria, Caturelli, Eugenio, Zoli, Marco, Borzio, Franco, Sacco, Rodolfo, Cabibbo, Giuseppe, Felder, Martina, Morisco, Filomena, Gasbarrini, Antonio, Baroni, Gianluca Svegliati, Foschi, Francesco G, Biasini, Elisabetta, Masotto, Alberto, Virdone, Roberto, Bernardi, Mauro, and Trevisani, Franco
- Subjects
Sorafenib ,Male ,Niacinamide ,medicine.medical_specialty ,Standard of care ,Carcinoma, Hepatocellular ,Antineoplastic Agents ,Gastroenterology ,Intermediate stage ,03 medical and health sciences ,0302 clinical medicine ,HCC ,BCLC-B ,Treatment ,Hepatology ,Internal medicine ,medicine ,Humans ,Chemoembolization, Therapeutic ,Propensity Score ,Aged ,Neoplasm Staging ,Retrospective Studies ,intermediate stage ,treatment ,business.industry ,Patient Selection ,Phenylurea Compounds ,Liver Neoplasms ,Settore MED/09 - MEDICINA INTERNA ,Standard of Care ,Middle Aged ,medicine.disease ,Survival Analysis ,Treatment Outcome ,Italy ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Propensity score matching ,Multivariate Analysis ,030211 gastroenterology & hepatology ,Female ,Liver function ,Liver cancer ,business ,medicine.drug - Abstract
Background and aims the Barcelona Clinic Liver Cancer intermediate stage (BCLC-B) of hepatocellular carcinoma (HCC) includes extremely heterogeneous patients in terms of tumor burden and liver function. Transarterial-chemoembolization (TACE) is the first-line treatment for these patients although it may be risky/useless for someone, while others could undergo curative treatments. This study assesses the treatment type performed in a large cohort of BCLC-B patients and its outcome. Methods retrospective analysis of 485 consecutive BCLC-B patients from the ITA.LI.CA database diagnosed with naive HCC after 1999. Patients were stratified by treatment. Results 29 patients (6%) were lost to follow-up before receiving treatment. Treatment distribution was: TACE (233, 51.1%), curative treatments (145 patients, 31.8%), sorafenib (18, 3.9%), other (39, 8.5%), best supportive care (BSC) (21, 4.6%). Median survival (95% CI) was 45 months (37.4-52.7) for curative treatments, 30 (24.7-35.3) for TACE, 14 (10.5-17.5) for sorafenib, 14 (5.2-22.7) for other treatments and 10 (6.0-14.2) for BSC (p
- Published
- 2017
5. Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study
- Author
-
Morisco, Filomena, Camera, Silvia, Guarino, Maria, Tortora, Raffaella, Cossiga, Valentina, Vitiello, Anna, Cordone, Gabriella, Caporaso, Nicola, Di Costanzo, Giovan Giuseppe, Zoli, M., Garuti, F., Neri, A., Piscaglia, F., Lenzi, B., Valente, M., Trevisani, F., Bolondi, L., Biselli, M., Caraceni, P., Cucchetti, A., Domenicali, M., Gramenzi, A., Magalotti, D., Serra, C., Venerandi, L., Cappelli, A., Golfieri, R., Mosconi, C., Renzulli, M., Giannini, E. G., Brunacci, M., Moscatelli, A., Pellegatta, G., Savarino, V., Caturelli, E., Roselli, P., Lauria, V., Pelecca, G., Dell'Isola, S., Ialungo, A. M., Rastrelli, E., Cabibbo, G., Cammà, C., Attardo, S., Rossi, M., Cavani, G., Virdone, R., Affronti, A., Nardone, G., Felder, M., Mega, A., Ciccarese, F., Del Poggio, P., Olmi, S., Foschi, F. G., Bevilacqua, V., Dall'Aglio, A. C., Ercolani, G., Fiorini, E., Casadei Gardini, A., Lanzi, A., Mirici Cappa, F., Sacco, R., Mismas, V., Svegliati Barone, G., Schiadà, L., Farinati, F., Gazzola, A., Murer, F., Pozzan, C., Vanin, V., Rapaccini, G. L., de Matthaeis, N., Gasbarrini, A., Rinninella, E., Olivani, A., Missale, G., Biasini, E., Di Marco, M., Balsamo, C., Vavassori, E., Masotto, A., Marchetti, F., Valerio, M., Marra, F., Aburas, S., Campani, C., Dragoni, G., Borzio, F., Benvegnù, L., Festi, D., Marasco, Giovanni, Ravaioli, Federico, Morisco, Filomena, Camera, Silvia, Guarino, Maria, Tortora, Raffaella, Cossiga, Valentina, Vitiello, Anna, Cordone, Gabriella, Caporaso, Nicola, Di Costanzo, Giovan Giuseppe, Zoli, M., Garuti, F., Neri, A., Piscaglia, F., Lenzi, B., Valente, M., Trevisani, F., Bolondi, L., Biselli, M., Caraceni, P., Cucchetti, A., Domenicali, M., Gramenzi, A., Magalotti, D., Serra, C., Venerandi, L., Cappelli, A., Golfieri, R., Mosconi, C., Renzulli, M., Giannini, E.G., Brunacci, M., Moscatelli, A., Pellegatta, G., Savarino, V., Caturelli, E., Roselli, P., Lauria, V., Pelecca, G., Dell'Isola, S., Ialungo, A.M., Rastrelli, E., Cabibbo, G., Cammà, C., Attardo, S., Rossi, M., Cavani, G., Virdone, R., Affronti, A., Nardone, G., Felder, M., Mega, A., Ciccarese, F., Del Poggio, P., Olmi, S., Foschi, F.G., Bevilacqua, V., Dall'Aglio, A.C., Ercolani, G., Fiorini, E., Casadei Gardini, A., Lanzi, A., Mirici Cappa, F., Sacco, R., Mismas, V., Svegliati Barone, G., Schiadà, L., Farinati, F., Gazzola, A., Murer, F., Pozzan, C., Vanin, V., Rapaccini, G.L., de Matthaeis, N., Gasbarrini, A., Rinninella, E., Olivani, A., Missale, G., Biasini, E., Di Marco, M., Balsamo, C., Vavassori, E., Masotto, A., Marchetti, F., Valerio, M., Marra, F., Aburas, S., Campani, C., Dragoni, G., Borzio, F., Benvegnù, L., Festi, D., Marasco, Giovanni, Ravaioli, Federico, Giannini, E. G., Ialungo, A. M., Foschi, F. G., Dall'Aglio, A. C., Rapaccini, G. L., Garuti, Franca, Venerandi, Laura, Mega, Angela, Fiorini, Elisabetta, Lanzi, Andrea, and Balsamo, Carlo
- Subjects
medicine.medical_specialty ,Large HCC ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Survival rate ,Laser ablation ,TACE ,Univariate analysis ,business.industry ,Standard treatment ,Large HCC, Laser ablation, TACE, Oncology ,Cancer ,Hepatology ,medicine.disease ,BCLC Stage ,Oncology ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,030211 gastroenterology & hepatology ,Liver cancer ,business ,Research Paper - Abstract
// Filomena Morisco 1 , Silvia Camera 1 , Maria Guarino 1 , Raffaella Tortora 2 , Valentina Cossiga 1 , Anna Vitiello 1 , Gabriella Cordone 2 , Nicola Caporaso 1 , Giovan Giuseppe Di Costanzo 2 and Italian Liver Cancer (ITA.LI.CA) group 1 Gastroenterology Unit, Department of Clinical Medicine and Surgery, University of Naples “Federico II”, Naples, Italy 2 Hepatology Unit, “Cardarelli” Hospital, Naples, Italy Correspondence to: Filomena Morisco, email: filomena.morisco@unina.it Keywords: large HCC; laser ablation; TACE Received: December 13, 2017 Accepted: February 27, 2018 Published: April 03, 2018 ABSTRACT Background: Limited therapies are available for large (≥40 mm) unresectable hepatocellular carcinoma (HCC). Currently, the standard treatment with transarterial chemoembolisation (TACE) is unsatisfactory with high recurrence rate and limited effect on survival. Laser Ablation (LA) has emerged as a relatively new technique characterized by high efficacy and good safety. This study is aimed to evaluate the efficacy of LA in comparison to TACE in patients with large HCC. Methods: Eighty-two patients with a single HCC nodule ≥40 mm (BCLC stage A or B) were enrolled in this case-control study. Forty-one patients were treated with LA and 41 patients were treated with TACE. Response to therapy was evaluated according to the mRECIST criteria. Survival was calculated with Kaplan-Meier from the time of cancer diagnosis to death with values censored at the date of the last follow-up. Results: Twenty-six (63.4%) and 8 (19.5%) patients had a complete response after LA and TACE, respectively ( p 60 mm. LA resulted superior to TACE especially in nodules ranging between 51 and 60 mm in diameter, with a complete response rate post-LA and post-TACE of 75% and 14.3%, respectively ( p = 0.0133). The 36 months cumulative survival rate in patients treated with LA and TACE was 55.4% and 48.8%, respectively. The disease recurrence rates after LA and TACE were 19.5% and 75.0%, respectively. Conclusions: LA is a more effective therapeutic option than TACE in patients with solitary large HCC.
- Published
- 2018
6. Reply to the comment on 'Assessing CN earthquake predictions in Italy' by G. Molchan, A. Peresan, G.F. Panza, L. Romashkova, V. Kossobokov
- Author
-
Taroni, M., Marzocchi, W., Roselli, P., Taroni, M., Marzocchi, W., and Roselli, P.
- Abstract
Molchan et al. (2017) raised concerns on the reliability of the main Taroni et al. (2016) conclusions…. © 2018 by the Istituto Nazionale di Geofisica e Vulcanologia. All rights reserved.
- Published
- 2018
7. Metabolic disorders across hepatocellular carcinoma in Italy
- Author
-
Morisco, F., Guarino, M., Valvano, M. R., Auriemma, F., Farinati, F., Giannini, E. G., Ciccarese, F., Tovoli, F., Rapaccini, Gian Ludovico, Di Marco, M., Caturelli, E., Zoli, M., Borzio, F., Sacco, R., Cabibbo, G., Felder, M., Benvengu, L., Gasbarrini, Antonio, Svegliati Baroni, G., Foschi, F. G., Biasini, E., Masotto, A., Virdone, R., Marra, F., Caporaso, N., Trevisani, F., Sessa, A., Marafatto, F., Peserico, G., Pozzan, C., Brunacci, M., Moscatelli, A., Pellegatta, G., Savarino, V., Del Poggio, P., Olmi, S., De Matthaeis, Nicoletta, Balsamo, C., Vavassori, E., Roselli, P., Lauria, V., Pelecca, G., Mismas, V., Rossi, M., Attardo, S., Cavani, G., Mega, A., Rinninella, Emanuele, Ortolani, A., Bevilacqua, V., Chiara Dall'Aglio, A., Ercolani, G., Fiorini, Carlo Ettore, Casadei Gardini, A., Lanzi, Alessio, Mirici Cappa, F., Missale, G., Porro, E., Marchetti, F., Valerio, M., Affronti, A., Orlando, E., Rosa Barcellona, M., Aburas, S., Dragoni, G., Campani, C., Biselli, M., Bucci, L., Caraceni, P., Cucchetti, A., Domenicali, M., Garuti, F., Gramenzi, A., Magalotti, D., Serra, C., Granito, A., Negrini, G., Napoli, L., Piscaglia, F., Morisco, F., Guarino, M., Valvano, M. R., Auriemma, F., Farinati, F., Giannini, E. G., Ciccarese, F., Tovoli, F., Rapaccini, G. L., Di Marco, M., Caturelli, E., Zoli, M., Borzio, F., Sacco, R., Cabibbo, G., Felder, M., Benvengu, L., Gasbarrini, A., Svegliati Baroni, G., Foschi, F. G., Biasini, E., Masotto, A., Virdone, R., Marra, F., Caporaso, N., Trevisani, F., Sessa, A., Marafatto, F., Peserico, G., Pozzan, C., Brunacci, M., Moscatelli, A., Pellegatta, G., Savarino, V., Del Poggio, P., Olmi, S., de Matthaeis, N., Balsamo, C., Vavassori, E., Roselli, P., Lauria, V., Pelecca, G., Mismas, V., Rossi, M., Attardo, S., Cavani, G., Mega, A., Rinninella, E., Ortolani, A., Bevilacqua, V., Chiara Dall'Aglio, A., Ercolani, G., Fiorini, E., Casadei Gardini, A., Lanzi, A., Mirici Cappa, F., Missale, G., Porro, E., Marchetti, F., Valerio, M., Affronti, A., Orlando, E., Rosa Barcellona, M., Aburas, S., Dragoni, G., Campani, C., Biselli, M., Bucci, L., Caraceni, P., Cucchetti, A., Domenicali, M., Garuti, F., Gramenzi, A., Magalotti, D., Serra, C., Granito, A., Negrini, G., Napoli, L., Piscaglia, F., Morisco, Filomena, Guarino, Maria, Valvano, Maria R., Auriemma, Francesco, Farinati, Fabio, Giannini, Edoardo G., Ciccarese, Francesca, Tovoli, Francesco, Rapaccini, Gian Ludovico, Di Marco, Maria, Caturelli, Eugenio, Zoli, Marco, Borzio, Franco, Sacco, Rodolfo, Cabibbo, Giuseppe, Felder, Martina, Benvengù, Luisa, Gasbarrini, Antonio, Svegliati Baroni, Gianluca, Foschi, Francesco G., Biasini, Elisabetta, Masotto, Alberto, Virdone, Roberto, Marra, Fabio, Caporaso, Nicola, Trevisani, Franco, Sessa, Anna, Marafatto, Filippo, Peserico, Giulia, Pozzan, Caterina, Brunacci, Matteo, Moscatelli, Alessandro, Pellegatta, Gaia, Savarino, Vincenzo, Del Poggio, Paolo, Olmi, Stefano, de Matthaeis, Nicoletta, Balsamo, Claudia, Vavassori, Elena, Roselli, Paola, Lauria, Valentina, Pelecca, Giorgio, Mismas, Valeria, Rossi, Margherita, Attardo, Simona, Cavani, Giulia, Mega, Andrea, Rinninella, Emanuele, Ortolani, Alessio, Bevilacqua, Vittoria, Chiara Dall'Aglio, Anna, Ercolani, Giorgio, Fiorini, Erica, Casadei Gardini, Andrea, Lanzi, Arianna, Mirici Cappa, Federica, Missale, Gabriele, Porro, Emanuela, Marchetti, Fabiana, Valerio, Matteo, Affronti, Andrea, Orlando, Emanuele, Rosa Barcellona, Maria, Aburas, Sami, Dragoni, Gabriele, Campani, Claudia, Biselli, Maurizio, Bucci, Laura, Caraceni, Paolo, Cucchetti, Alessandro, Domenicali, Marco, Garuti, Francesca, Gramenzi, Annagiulia, Magalotti, Donatella, Serra, Carla, Granito, Alessandro, Negrini, Giulia, Napoli, Lucia, Piscaglia, Fabio, Valvano, Maria R, Giannini, Edoardo G, and Foschi, Francesco G
- Subjects
Oncology ,Male ,obesity ,Databases, Factual ,Hepatocellular carcinoma ,0302 clinical medicine ,Risk Factors ,Prospective cohort study ,diabetes ,Metabolic disorder ,Liver Neoplasms ,Diabetes ,hepatocellular carcinoma ,Middle Aged ,Metabolic syndrome ,Portal vein thrombosis ,Italy ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Female ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Settore MED/12 - GASTROENTEROLOGIA ,Obesity ,metabolic syndrome ,03 medical and health sciences ,Databases ,Metabolic Diseases ,Internal medicine ,medicine ,Diabetes Mellitus ,Humans ,Factual ,Aged ,Neoplasm Staging ,Retrospective Studies ,Hepatology ,business.industry ,Carcinoma ,Hepatocellular ,medicine.disease ,Survival Analysis ,BCLC Stage ,Multivariate Analysis ,diabete ,Liver function ,business - Abstract
Background: Metabolic disorders are well-known risk factors for HCC. Conversely, their impact on the natural history of HCC is not established. This study aimed at evaluating the impact of metabolic disorders on clinical features, treatment and survival of HCC patients regardless of its aetiology. Methods: We analysed the ITA.LI.CA database regarding 839 HCC patients prospectively collected. The following metabolic features were analysed: BMI, diabetes, arterial hypertension, hypercholesterolaemia and hypertriglyceridaemia. According to these features, patients were divided into 3 groups: 0-1, 2 and 3-5 metabolic features. Results: As compared with patients with 0-1 metabolic features, patients with 3-5 features showed lower percentage of HCC diagnosis on surveillance (P=.021), larger tumours (P=.038), better liver function (higher percentage of Child-Pugh class A [P=.007] and MELD 
- Published
- 2018
8. Enteral versus intravenous approach for the sedation of critically ill patients: A randomized and controlled trial 11 Medical and Health Sciences 1103 Clinical Sciences
- Author
-
Mistraletti, G., Umbrello, M., Salini, Sara, Cadringher, P., Formenti, P., Chiumello, D., Villa, C., Russo, R., Francesconi, S., Valdambrini, F., Bellani, G., Palo, A., Riccardi, F., Ferretti, E., Festa, M., Gado, A. M., Taverna, M., Pinna, C., Barbiero, A., Ferrari, P. A., Iapichino, G., Morabito, A., Langer, M., Valenza, F., Malacrida, R., Rambaldi, M., Spanu, P., Anania, S., Andrighi, E., Di Carlo, A., Martinetti, F., Barello, Serena, Noto, A., Capello, G., Sabatelli, B., Brenna, G., Astori, M., Placido, P., Gattinoni, L., Protti, A., Pagan, F., Berto, V., Roselli, P., Ronzoni, G., Beck, E., Gaiotto, M., Radrizzani, D., Ferla, L., Giudici, R., Merlini, L., Pesenti, A., La Bruna, A., Rezoagli, E., Lucchini, A., Braschi, A., Niebel, T., Selvini, M., Cortesi, S., Quaini, A., Iotti, G., Contri, E., Sacchi, A., Livigni, S., Naretto, G., Deprado, A., Venturi Degli Esposti, V., Caironi, P., Radeschi, G., Odetto, L., Ferrero, D., Cognolato, S., Penso, R., Vacchelli, R., Cardellino, S., Bosco, E., Bresciani, A., Pozzo, I., Alessio, A., Clarindo Rodrigues, V., Biase, E., Vivaldi, N., Nava, A., Ponzetta, F., Bavutti, L., Martina, P., Palacios, B., and Bergonzini, G.
- Subjects
Male ,Simplified Acute Physiology Score ,Patient care planning ,Critical Illness ,Central Nervous System Depressants ,Hypnotics and sedatives ,Antipruritics ,Middle Aged ,Hydroxyzine ,Melatonin ,Nursing education research ,Aged ,Anesthesia ,Deep Sedation ,Enteral Nutrition ,Female ,Humans ,Hypnotics and Sedatives ,Intensive Care Units ,Poisson Distribution ,Single-Blind Method ,Settore MED/41 - ANESTESIOLOGIA - Published
- 2019
9. Feedup, feedback, and feedforward in curve mid-air 3D gestures
- Author
-
Burny, N, Kieffer, S, Magrofuoco, N, Perez Medina, Jl, Roselli, P, Vanderdonckt, J, and Vas, A
- Subjects
Gesture interaction ,Settore MAT/01 ,3D gesture ,Feedback - Published
- 2018
10. The integration of stress, strain, and seismogenic fault data : towards more robust estimates of the earthquake potential in Italy and its surroundings
- Author
-
CAPORALI, ALESSANDRO, BRAITENBERG, CARLA, MORSUT, FEDERICO, PIVETTA, TOMMASO FERRUCCIO, MARIA, Burrato, P., Carafa, M., Di Giovambattista, R., Gentili, S., Mariucci, M. T., Mastrolembo Ventura, B., Montone, P., Nicolini, F., Roselli, P., Rossi, G., Valensise, G. L., Vigano, A., 102° Congresso Nazionale, Societa' Italiana di Fisica, Caporali, Alessandro, Braitenberg, Carla, Burrato, P., Carafa, M., Di Giovambattista, R., Gentili, S., Mariucci, M. T., Mastrolembo Ventura, B., Montone, P., Morsut, Federico, Nicolini, F., Pivetta, TOMMASO FERRUCCIO MARIA, Roselli, P., Rossi, G., Valensise, G. L., and Vigano, A.
- Subjects
strain rate ,GNSS ,strain rate, GNSS, earthquake potential ,earthquake potential - Abstract
The large networks and datasets over the past two decades (GPS/Geodetic, in situ stress, seismic catalogues, seismogenic sources) describe independent aspects of the seismic cycle. They help constraining the rate of loading/unloading of the faults listed in the DISS (Database of Individual Seismogenic Sources) of INGV. We use the geodetic strain rate to compute the Coulomb Failure Function on the fault planes of the DISS, i.e. the rate at which the regional stress is transferred to each fault; as its sign can be positive or negative, the Coulomb Failure Function rate should ultimately indicate the rate at which every fault for which sufficient geodetic data are available is loading or unloading elastic energy. Our results may ultimately contribute to the assessment of time-dependent seismic hazard in Italy, thus complementing the time-independent approach used for conventional seismic hazard maps.GPS
- Published
- 2016
11. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
- Author
-
Piscaglia, Fabio, Svegliati Baroni, Gianluca, Barchetti, Andrea, Pecorelli, Anna, Marinelli, Sara, Tiribelli, Claudio, Bellentani, Stefano, Bernardi M, Biselli M, Bernardi M, Biselli M, Caraceni P, Domenicali M, Garuti F, Gramenzi A, Lenzi B, Magalotti D, Cescon M, Ravaioli M, Del Poggio P, Olmi S, Rapaccini GL, Balsamo C, Di Nolfo MA, Vavassori E, Alberti A, Benvegnù L, Gatta A, Giacomin A, Vanin V, Pozzan C, Maddalo G, Giampalma E, Cappelli A, Golfieri R, Mosconi C, Renzulli M, Roselli P, Dell'Isola S, Ialungo AM, Risso D, Marenco S, Sammito G, Bruzzone L, Bosco G, Grieco A, Pompili M, Rinninella E, Siciliano M, Chiaramonte M, Guarino M, Cammà C, Maida M, Costantino A, Barcellona MR, Schiadà L, Gemini S, Lanzi A, Stefanini GF, Dall'Aglio AC, Cappa FM, Suzzi A, Mussetto A, Treossi O, Missale G, Porro E, Mismas V, Vivaldi C, Bolondi L, Zoli M, Granito A, Malagotti D, Tovoli F, Trevisani F, Venerandi L, Brandi G, Cucchetti A, Bugianesi E, Vanni E, Mezzabotta L, Cabibbo G, Petta S, Fracanzani A, Fargion S, Marra F, Fani B, Biasini E, Sacco R, CAPORASO, NICOLA, Colombo M, D'Ambrosio R, Crocè LS, Patti R, Giannini EG, Loria P, Lonardo A, Baldelli E, Miele L, Farinati F, Borzio M, Dionigi E, Soardo G, Caturelli E, Ciccarese F, Virdone R, Affronti A, Foschi FG, Borzio F., MORISCO, FILOMENA, Piscaglia, Fabio, Svegliati Baroni, Gianluca, Barchetti, Andrea, Pecorelli, Anna, Marinelli, Sara, Tiribelli, Claudio, Bellentani, Stefano, Bernardi M, Biselli M, Bernardi, M, Biselli, M, Caraceni, P, Domenicali, M, Garuti, F, Gramenzi, A, Lenzi, B, Magalotti, D, Cescon, M, Ravaioli, M, Del Poggio, P, Olmi, S, Rapaccini, Gl, Balsamo, C, Di Nolfo, Ma, Vavassori, E, Alberti, A, Benvegnù, L, Gatta, A, Giacomin, A, Vanin, V, Pozzan, C, Maddalo, G, Giampalma, E, Cappelli, A, Golfieri, R, Mosconi, C, Renzulli, M, Roselli, P, Dell'Isola, S, Ialungo, Am, Risso, D, Marenco, S, Sammito, G, Bruzzone, L, Bosco, G, Grieco, A, Pompili, M, Rinninella, E, Siciliano, M, Chiaramonte, M, Guarino, M, Cammà, C, Maida, M, Costantino, A, Barcellona, Mr, Schiadà, L, Gemini, S, Lanzi, A, Stefanini, Gf, Dall'Aglio, Ac, Cappa, Fm, Suzzi, A, Mussetto, A, Treossi, O, Missale, G, Porro, E, Mismas, V, Vivaldi, C, Bolondi, L, Zoli, M, Granito, A, Malagotti, D, Tovoli, F, Trevisani, F, Venerandi, L, Brandi, G, Cucchetti, A, Bugianesi, E, Vanni, E, Mezzabotta, L, Cabibbo, G, Petta, S, Fracanzani, A, Fargion, S, Marra, F, Fani, B, Biasini, E, Sacco, R, Morisco, Filomena, Caporaso, Nicola, Colombo, M, D'Ambrosio, R, Crocè, L, Patti, R, Giannini, Eg, Loria, P, Lonardo, A, Baldelli, E, Miele, L, Farinati, F, Borzio, M, Dionigi, E, Soardo, G, Caturelli, E, Ciccarese, F, Virdone, R, Affronti, A, Foschi, Fg, Borzio, F., Fabio Piscagliaxxx, Gianluca Svegliati-Baroni, Andrea Barchetti, Anna Pecorellixxx, Sara Marinellixxx, Claudio Tiribelli, and, Stefano Bellentani, on behalf of the HCC-NAFLD Italian Study Group [, Mauro Bernardi, Maurizio Biselli, Paolo Caraceni, Marco Domenicali, Francesca Garuti, Annagiulia Gramenzi, Barbara Lenzi, Donatella Magalotti, Matteo Cescon, Matteo Ravaioli, Emanuela Giampalma, Rita Golfieri, Cristina Mosconi, Luigi Bolondi, Marco Zoli, Alessandro Granito, Francesco Tovoli, Franco Trevisani, Laura Venerandi, Giovanni Brandi, Alessandro Cucchetti, ], DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE, DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE, Facolta' di MEDICINA e CHIRURGIA, AREA MIN. 06 - Scienze mediche, Da definire, Croce', Saveria, and HCC NAFLD Italian Study, Group
- Subjects
Male ,Cirrhosis ,Survival ,Chronic liver disease ,Gastroenterology ,0302 clinical medicine ,Non-alcoholic Fatty Liver Disease ,Nonalcoholic fatty liver disease ,80 and over ,Prospective Studies ,Chronic ,Prospective cohort study ,Aged, 80 and over ,Medicine (all) ,Liver Neoplasms ,hepatocellular carcinoma ,Middle Aged ,Hepatitis C ,Liver Neoplasm ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Competing risk analysi ,030211 gastroenterology & hepatology ,Female ,Non Alcoholic SteatoHepatitis=NASH ,Human ,medicine.medical_specialty ,Aged ,Carcinoma, Hepatocellular ,Hepatitis C, Chronic ,Humans ,Hepatology ,Competing risk analysis ,Milan criteria ,03 medical and health sciences ,Internal medicine ,medicine ,Survival rate ,business.industry ,Settore MED/09 - MEDICINA INTERNA ,Carcinoma ,nutritional and metabolic diseases ,Hepatocellular ,medicine.disease ,digestive system diseases ,Nonalcoholic fatty liver disease, hepatocellular carcinoma, clinical patterns ,business ,clinical patterns - Abstract
none 31 no Nonalcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome and may evolve into hepatocellular carcinoma (HCC). Only scanty clinical information is available on HCC in NAFLD. The aim of this multicenter observational prospective study was to assess the clinical features of patients with NAFLD-related HCC (NAFLD-HCC) and to compare them to those of hepatitis C virus (HCV)-related HCC. A total of 756 patients with either NAFLD (145) or HCV-related chronic liver disease (611) were enrolled in secondary care Italian centers. Survival was modeled according to clinical parameters, lead-time bias, and propensity analysis. Compared to HCV, HCC in NAFLD patients had a larger volume, showed more often an infiltrative pattern, and was detected outside specific surveillance. Cirrhosis was present in only about 50% of NAFLD-HCC patients, in contrast to the near totality of HCV-HCC. Regardless of tumor stage, survival was significantly shorter (P = 0.017) in patients with NAFLD-HCC, 25.5 months (95% confidence interval 21.9-29.1), than in those with HCV-HCC, 33.7 months (95% confidence interval 31.9-35.4). To eliminate possible confounders, a propensity score analysis was performed, which showed no more significant difference between the two groups. Additionally, analysis of patients within Milan criteria submitted to curative treatments did not show any difference in survival between NAFLD-HCC and HCV-HCC (respectively, 38.6 versus 41.0 months, P = nonsignificant) CONCLUSIONS: NAFLD-HCC is more often detected at a later tumor stage and could arise also in the absence of cirrhosis, but after patient matching, it has a similar survival rate compared to HCV infection; a future challenge will be to identify patients with NAFLD who require more stringent surveillance in order to offer the most timely and effective treatment. Fabio Piscagliaxxx; Gianluca Svegliati-Baroni; Andrea Barchetti; Anna Pecorellixxx; Sara Marinellixxx; Claudio Tiribelli; and; Stefano Bellentani; on behalf of the HCC-NAFLD Italian Study Group [;Mauro Bernardi; Maurizio Biselli; Paolo Caraceni; Marco Domenicali; Francesca Garuti; Annagiulia Gramenzi; Barbara Lenzi; Donatella Magalotti; Matteo Cescon; Matteo Ravaioli; Emanuela Giampalma; Rita Golfieri; Cristina Mosconi; Luigi Bolondi; Marco Zoli; Alessandro Granito; Francesco Tovoli; Franco Trevisani; Laura Venerandi; Giovanni Brandi; Alessandro Cucchetti;] Fabio Piscagliaxxx; Gianluca Svegliati-Baroni; Andrea Barchetti; Anna Pecorellixxx; Sara Marinellixxx; Claudio Tiribelli; and; Stefano Bellentani; on behalf of the HCC-NAFLD Italian Study Group [;Mauro Bernardi; Maurizio Biselli; Paolo Caraceni; Marco Domenicali; Francesca Garuti; Annagiulia Gramenzi; Barbara Lenzi; Donatella Magalotti; Matteo Cescon; Matteo Ravaioli; Emanuela Giampalma; Rita Golfieri; Cristina Mosconi; Luigi Bolondi; Marco Zoli; Alessandro Granito; Francesco Tovoli; Franco Trevisani; Laura Venerandi; Giovanni Brandi; Alessandro Cucchetti;]
- Published
- 2016
12. The integration of stress, strain, and seismogenic fault data : towards more robust estimates of the earthquake potential in Italy and its surroundings
- Author
-
Caporali, A., Burrato, P., Carafa, M., Di Giovambattista, R., Gentili, S., Mariucci, M. T., Montone, P., Nicolini, L., Roselli, P., Rossi, G., Valensise, G. L., Vigano, A., BRAITENBERG, CARLA, MORSUT, FEDERICO, PIVETTA, TOMMASO FERRUCCIO, MARIA, European Geosciences Union, Caporali, A., Braitenberg, Carla, Burrato, P., Carafa, M., Di Giovambattista, R., Gentili, S., Mariucci, M. T., Montone, P., Morsut, Federico, Nicolini, L., Pivetta, TOMMASO FERRUCCIO MARIA, Roselli, P., Rossi, G., Valensise, G. L., and Vigano, A.
- Subjects
strain ,earthquake potential, seismogenic sources, strain ,seismogenic sources ,earthquake potential - Abstract
Italy is an earthquake-prone country with a long tradition in observational seismology. For many years, the country’s unique historical earthquake record has revealed fundamental properties of Italian seismicity and has been used to determine earthquake rates. Paleoseismological studies conducted over the past 20 years have shown that the length of this record - 5 to 8 centuries, depending on areas - is just a fraction of the typical recurrence interval of Italian faults - consistently larger than a millennium. Hence, so far the earthquake potential may have been significantly over- or under-estimated. Based on a clear perception of these circumstances, over the past two decades large networks and datasets describing independent aspects of the seismic cycle have been developed. INGV, OGS, some universities and local administrations have built networks that globally include nearly 500 permanent GPS/GNSS sites, routinely used to compute accurate horizontal velocity gradients reflecting the accumulation of tectonic strain. INGV developed the Italian present-day stress map, which includes over 700 datapoints based on geophysical in-situ measurements and fault plane solutions, and the Database of Individual Seismogenic Sources (DISS), a unique compilation featuring nearly 300 three-dimensional seismogenic faults over the entire nation. INGV also updates and maintains the Catalogo Parametrico dei Terremoti Italiani (CPTI) and the instrumental earthquake database ISIDe, whereas OGS operates its own seismic catalogue for northeastern Italy. We present preliminary results on the use of this wealth of homogeneously collected and updated observations of stress and strain as a source of loading/unloading of the faults listed in the DISS database. We use the geodetic strain rate - after converting it to stress rate in conjunction with the geophysical stress data of the Stress Map - to compute the Coulomb Failure Function on all fault planes described by the DISS database. This may be seen as an indicator of the rate at which the regional stress is transferred to each fault; as its sign can be positive or negative, the Coulomb Failure Function rate should ultimately indicate the rate at which every fault for which sufficient geodetic data are available is loading or unloading elastic energy. A better understanding of the relationships among geodetically-documented strains, present-day stress, active faulting and seismicity for the entire country should enable us to outline regions where the current strains explain well the known seismicity and to single out areas where stress is consistently building up but are historically quiescent. In such areas the lack of seismicity may result from a limited earthquake coupling – i.e. current strains are consumed aseismically - or from the incompleteness of the earthquake record. Our results may ultimately contribute to the assessment of time-dependent seismic hazard in Italy, thus complementing the time-independent approach used for conventional seismic hazard maps.
- Published
- 2016
13. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma
- Author
-
Cucchetti A., Trevisani F., Pecorelli A., Erroi V., Farinati F., Ciccarese F., Rapaccini G. L., Di Marco M., Caturelli E., Giannini E. G., Zoli M., Borzio F., Cabibbo G., Felder M., Gasbarrini A., Sacco R., Foschi F. G., Missale G., Morisco F., Baroni G. S., Virdone R., Bernardi M., Pinna A. D., Bolondi L., Biselli M., Caraceni P., Garuti F., Gramenzi A., Lenzi B., Magalotti D., Piscaglia F., Serra C., Ravaioli M., Venerandi L., Del Poggio P., Olmi S., Balsamo C., Di Nolfo M. A., Vavassori E., Alberti A., Benvegnu L., Gatta A., Giacomin A., Vanin V., Pozzan C., Maddalo G., Giampalma E., Cappelli A., Golfieri R., Mosconi C., Renzulli M., Dell'Isola S., Ialungo A. M., Roselli P., Risso D., Marenco S., Sammito G., Bruzzone L., Bosco G., Grieco A., Pompili M., Rinninella E., Siciliano M., Chiaramonte M., Guarino M., Camma C., Maida M., Di Martino A., Barcellona M. R., Schiada L., Gemini S., Biasini E., Porro E., del Ricambio M., Mismas V., Vivaldi C., Cucchetti, A, Trevisani, F, Pecorelli, A, Erroi, V, Farinati, F, Ciccarese, F, Rapaccini, Gl, Di Marco, M, Caturelli, E, Giannini, Eg, Zoli, M, Borzio, F, Cabibbo, G, Felder, M, Gasbarrini, A, Sacco, R, Foschi, Fg, Missale, G, Morisco, Filomena, Baroni, G, Virdone, R, Bernardi, M, Pinna, Ad, Italian Liver Cancer, Group, Alessandro, Cucchetti, Franco, Trevisani, Anna, Pecorelli, Virginia, Erroi, Fabio, Farinati, Francesca, Ciccarese, Gian, Lodovico Rapaccini, Mariella Di, Marco, Eugenio, Caturelli, Edoardo, G. Giannini, Marco, Zoli, Franco, Borzio, Giuseppe, Cabibbo, Martina, Felder, Antonio, Gasbarrini, Rodolfo, Sacco, Francesco, Giuseppe Foschi, Gabriele, Missale, Filomena, Morisco, Gianluca, Svegliati Baroni, Roberto, Virdone, Mauro, Bernardi, Antonio D., Pinna, for the Italian Liver Cancer Group [.., Bolondi, Luigi, Maurizio, Biselli, Piscaglia, Fabio, ]., Cucchetti, A., Trevisani, F., Pecorelli, A., Erroi, V., Farinati, F., Ciccarese, F., Rapaccini, G. L., Di Marco, M., Caturelli, E., Giannini, E. G., Zoli, M., Borzio, F., Cabibbo, G., Felder, M., Gasbarrini, A., Sacco, R., Foschi, F. G., Missale, G., Morisco, F., Baroni, G. S., Virdone, R., Bernardi, M., Pinna, A. D., Bolondi, L., Biselli, M., Caraceni, P., Garuti, F., Gramenzi, A., Lenzi, B., Magalotti, D., Piscaglia, F., Serra, C., Ravaioli, M., Venerandi, L., Del Poggio, P., Olmi, S., Balsamo, C., Di Nolfo, M. A., Vavassori, E., Alberti, A., Benvegnu, L., Gatta, A., Giacomin, A., Vanin, V., Pozzan, C., Maddalo, G., Giampalma, E., Cappelli, A., Golfieri, R., Mosconi, C., Renzulli, M., Dell'Isola, S., Ialungo, A. M., Roselli, P., Risso, D., Marenco, S., Sammito, G., Bruzzone, L., Bosco, G., Grieco, A., Pompili, M., Rinninella, E., Siciliano, M., Chiaramonte, M., Guarino, M., Camma, C., Maida, M., Di Martino, A., Barcellona, M. R., Schiada, L., Gemini, S., Biasini, E., Porro, E., del Ricambio, M., Mismas, V., and Vivaldi, C.
- Subjects
Male ,medicine.medical_specialty ,Pediatrics ,Carcinoma, Hepatocellular ,Time Factors ,Hepatocellular carcinoma ,Settore MED/12 - GASTROENTEROLOGIA ,Disease ,Gastroenterology ,Bias ,Internal medicine ,Overall survival ,medicine ,Humans ,Early Detection of Cancer ,Aged ,Estimation ,Surveillance ,Hepatology ,business.industry ,Liver Neoplasms ,medicine.disease ,digestive system diseases ,Lead time bias ,Cirrhosis ,Female ,business ,Lead-time bias ,Follow-Up Studies - Abstract
Lead-time is the time by which diagnosis is anticipated by screening/surveillance with respect to the symptomatic detection of a disease. Any screening program, including surveillance for hepatocellular carcinoma (HCC), is subject to lead-time bias. Data regarding lead-time for HCC are lacking. Aims of the present study were to calculate lead-time and to assess its impact on the benefit obtainable from the surveillance of cirrhotic patients. Background & Aims: Lead-time is the time by which diagnosis is anticipated by screening/surveillance with respect to the symptomatic detection of a disease. Any screening program, including surveillance for hepatocellular carcinoma (HCC), is subject to lead-time bias. Data regarding lead-time for HCC are lacking. Aims of the present study were to calculate lead-time and to assess its impact on the benefit obtainable from the surveillance of cirrhotic patients. Methods: One-thousand three-hundred and eighty Child–Pugh class A/B patients from the ITA.LI.CA database, in whom HCC was detected during semiannual surveillance (n = 850), annual surveillance (n = 234) or when patients came when symptomatic (n = 296), were selected. Lead-time was estimated by means of appropriate formulas and Monte Carlo simulation, including 1000 patients for each arm. Results: The 5-year overall survival after HCC diagnosis was 32.7% in semiannually surveilled patients, 25.2% in annually surveilled patients, and 12.2% in symptomatic patients (p
- Published
- 2014
14. Clinical Patterns of hepatocellular carcinoma (HCC) in Non Alcoholic Fatty Liver Disease (NAFLD): a multicenter case-control study
- Author
-
Piscaglia, F., Svegliati Baroni, G., Barchetti, A., Pecorelli, A., Marinelli, S., Tiribelli, C., Bellentani e. gruppo studio italiano HCC NAFLD composto da: L. Bolondi, S. Bellentani e. gruppo studio italiano HCC NAFLD composto da: L. Bolondi, Zoli, M., Malagotti, D., Vanni, Ester, Mezzabotta, Lavinia, Cabibbo, G., Petta, S., Fracanzani, A., Fargion, S., Marra, F., Fani, B., Sacco, R., Morisco, F., Caporaso, N., Guarino, M., Colombo, M., D’Ambrosio, R., Crocè, L. S., Patti, R., Giannini, E., Lonardo, A., Baldelli, E., Miele, L., Grieco, A., Farinati, F., Pozzan, C., Borzio, M., Dionigi, E., Soardo, G., Roselli, P., Ciccarese, F., Virdone, F., Affronti, A., Boschi, F. G., Borzio, F., Trevisani, F., and Bugianesi, Elisabetta
- Published
- 2015
15. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis
- Author
-
Giannini, EG, Marenco, S, Borgonovo, G, Savarino, V, Farinati, F, Del Poggio, P, Rapaccini, GL, Di Nolfo, MA, Benvegnu, L, ZOLI, MARCO, Borzio, F, Caturelli, E, Chiaramonte, M, TREVISANI, FRANCO, Italian Liver Canc ITA LI CA Grp [. . ., BERNARDI, MAURO, BISELLI, MAURIZIO, CASSINI, ROMINA, CARACENI, PAOLO, DOMENICALI, MARCO, Erroi V, FRIGERIO, MARTA, GRAMENZI, ANNAGIULIA, Lenzi B, Magalotti D, Balsamo C, Di Marco M, Vavassori E, Gilardoni L, Mattiello M, Alberti A, Gatta A, Gios M, Giacomin A, Vanin V, Pozzan C, Maddalo G, RAVAIOLI, MATTEO, CUCCHETTI, ALESSANDRO, Giampalma E, Golfieri R, MOSCONI, CRISTINA, RENZULLI, MATTEO, Ghittoni G, Roselli P, Bosco G, Giannini, EG, Marenco, S, Borgonovo, G, Savarino, V, Farinati, F, Del Poggio, P, Rapaccini, GL, Di Nolfo, MA, Benvegnu, L, Zoli, M, Borzio, F, Caturelli, E, Chiaramonte, M, Trevisani, F, Italian Liver Canc ITA LI CA Grp [.., Bernardi M, Biselli M, Cassini R, Caraceni P, Domenicali M, Erroi V, Frigerio M, Gramenzi A, Lenzi B, Magalotti D, Balsamo C, Di Marco M, Vavassori E, Gilardoni L, Mattiello M, Alberti A, Gatta A, Gios M, Giacomin A, Vanin V, Pozzan C, Maddalo G, Ravaioli M, Cucchetti A, Giampalma E, Golfieri R, Mosconi C, Renzulli M, Ghittoni G, Roselli P, Bosco G, and ].
- Subjects
Liver Cirrhosis ,Male ,Cirrhosis ,IMPACT ,medicine.medical_treatment ,MULTICENTER ,Kaplan-Meier Estimate ,Liver transplantation ,Gastroenterology ,RECOMMENDATIONS ,Cohort Studies ,Aged, 80 and over ,Biopsy, Needle ,Liver Neoplasms ,ASSOCIATION ,Middle Aged ,Prognosis ,LIVER-TRANSPLANTATION ,Immunohistochemistry ,Hepatocellular carcinoma ,SURVIVAL ,Female ,alpha-Fetoproteins ,Liver cancer ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,RESECTION ,Risk Assessment ,Sensitivity and Specificity ,Statistics, Nonparametric ,Internal medicine ,Biomarkers, Tumor ,medicine ,Hepatectomy ,Humans ,Neoplasm Invasiveness ,Aged ,Neoplasm Staging ,Retrospective Studies ,Tumor marker ,Hepatology ,Performance status ,business.industry ,CLINICAL-FEATURES ,medicine.disease ,Survival Analysis ,digestive system diseases ,ADVANCED HEPATITIS-C ,ROC Curve ,PERCUTANEOUS ETHANOL INJECTION ,Percutaneous ethanol injection ,business - Abstract
Alpha-fetoprotein is a tumor marker that has been used for surveillance and diagnosis of hepatocellular carcinoma (HCC) in patients with cirrhosis. The prognostic capability of this marker in patients with HCC has not been clearly defined. In this study our aim was to evaluate the prognostic usefulness of serum alpha-fetoprotein in patients with well-compensated cirrhosis, optimal performance status, and small HCC identified during periodic surveillance ultrasound who were treated with curative intent. Among the 3,027 patients included in the Italian Liver Cancer study group database, we selected 205 Child-Pugh class A and Eastern Cooperative Group Performance Status 0 patients with cirrhosis with a single HCC ≤3 cm of diameter diagnosed during surveillance who were treated with curative intent (hepatic resection, liver transplantation, percutaneous ethanol injection, radiofrequency thermal ablation). Patients were subdivided according to alpha-fetoprotein serum levels (i.e., normal ≤20 ng/mL; mildly elevated 21-200 ng/mL; markedly elevated >200 ng/mL). Patient survival, as assessed by the Kaplan-Meier method, was not significantly different among the three alpha-fetoprotein classes (P = 0.493). The same result was obtained in the subgroup of patients with a single HCC ≤2 cm (P = 0.714). An alpha-fetoprotein serum level of 100 ng/mL identified by receiver operating characteristic curve had inadequate accuracy (area under the curve = 0.536, 95% confidence interval = 0.465-0.606) to discriminate between survivors and deceased patients. Conclusion: Alpha-fetoprotein serum levels have no prognostic meaning in well-compensated cirrhosis patients with single, small HCC treated with curative intent. (HEPATOLOGY 2012)
- Published
- 2012
16. Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population
- Author
-
CUCCHETTI, ALESSANDRO, TREVISANI, FRANCO, CESCON, MATTEO, ERCOLANI, GIORGIO, ZOLI, MARCO, PINNA, ANTONIO DANIELE, GRAMENZI, ANNAGIULIA, Farinati F., Poggio P. D., Rapaccini G., Nolfo M. A., Benvegnù L., Borzio F., Giannini E. G., Caturelli E., Chiaramonte M., BERNARDI, MAURO, Buccione D., CARACENI, PAOLO, Domenicali M., Erroi V., Fatti G., Frigerio M., Santi V., Magalotti D., Balsamo C., DI MARCO, MARIACRISTINA, Vavassori E., Gilardoni L., Mattiello M., Alberti A., Gatta A., Gios M., Cazzagon N., Giacomin A., Pozzan C., Sergio A., Vanin V., Giampalma E., Golfieri R., Mosconi C., Renzulli M., Ghittoni G., Roselli P., Bodini G., Corbo M., Savarino V., DOMENICALI, MARCO, Cucchetti A., Trevisani F., Cescon M., Ercolani G., Farinati F., Poggio P.D., Rapaccini G., Nolfo M.A., Benvegnù L., Zoli M., Borzio F., Giannini E.G., Caturelli E., Chiaramonte M., Pinna A.D., Bernardi M., Buccione D., Caraceni P., Domenicali M., Erroi V., Fatti G., Frigerio M., Gramenzi A., Santi V., Magalotti D., Balsamo C., Di Marco M., Vavassori E., Gilardoni L., Mattiello M., Alberti A., Gatta A., Gios M., Cazzagon N., Giacomin A., Pozzan C., Sergio A., Vanin V., Giampalma E., Golfieri R., Mosconi C., Renzulli M., Ghittoni G., Roselli P., Bodini G., Corbo M., and Savarino V.
- Subjects
Adult ,Liver Cirrhosis ,Male ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Cost effectiveness ,Cost-Benefit Analysis ,medicine.medical_treatment ,Population ,COST-EFFECTIVENESS ANALYSIS ,Liver transplantation ,Risk Factors ,Internal medicine ,SURVEILLANCE ,medicine ,Humans ,HEPATOCELLULAR CARCINOMA ,Intensive care medicine ,education ,Survival rate ,CIRRHOSIS ,Aged ,Aged, 80 and over ,education.field_of_study ,Hepatology ,Relative survival ,business.industry ,Incidence ,Liver Neoplasms ,Odds ratio ,Middle Aged ,Prognosis ,medicine.disease ,Markov Chains ,Survival Rate ,Italy ,Population Surveillance ,Female ,business ,Liver cancer ,Incremental cost-effectiveness ratio - Abstract
BACKGROUND AND AIMS: It was recently shown that semi-annual surveillance for hepatocellular carcinoma (HCC) in cirrhotic patients provides a prognostic advantage over the annual program; however, its cost-effectiveness (CE) in the general cirrhotic population still needs to be defined. METHODS: A Markov model was built to compare CE of these two strategies, considering literature results and treatment modalities of 918 cirrhotic patients from the Italian Liver Cancer (ITA.LI.CA) database. RESULTS: Results from the Markov model suggest that, compared to annual surveillance, semi-annual surveillance leads to a gain in quality-adjusted life expectancy, in an unselected cirrhotic population, of 1.35 quality-adjusted life-months (QALMs) over 10 years since surveillance start in compensated patients, and of 0.73 QALMs in decompensated patients. Semi-annual surveillance was more cost-effective in compensated than in decompensated cirrhosis, with an incremental CE ratio (ICER) of 1997 and 3814€/QALM, respectively. In compensated cirrhosis, semi-annual surveillance was more cost-effective than the annual program when the annual HCC incidence was ≥3.2% and the relative survival gain after cancer diagnosis was ≥20% with respect to the annual program. In decompensated cirrhosis, semi-annual surveillance was cost-effective in patients amenable to liver transplantation. In both groups, CE of semi-annual surveillance improved with the increase of annual incidence and the survival benefit obtainable with HCC treatment. CONCLUSIONS: Both surveillance strategies for HCC in cirrhotic patients can be recommended, according to the individual risk profile for HCC occurrence and the expected survival gain obtainable after tumor diagnosis and therapy.
- Published
- 2012
17. Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy
- Author
-
Farinati Fabio, Giacomin Anna, Vanin Veronica, Sergio Adriana, Burra Patrizia, Cillo Umberto, Di Nolfo Annamaria, Del Poggio Paolo, Benvegnu Luisa, Zoli Marco, Borzio Franco, Giannini Edoardo, Caturelli Eugenio, Cazzagon Nora, Rapaccini Gian Ludovico, Trevisani Franco, for the Italian Liver Cancer (ITA. LI. CA) group, Andreone P, Bernardi M, Biselli M, Caraceni P, di Micoli A, Domenicali M, Magalotti D, Cappa FM, Santi V, Zambruni A, Balsamo C, Di Marco M, Vavassori E, Gilardoni L, Mattiello M, Alberti A, Gatta A, Gios M, Molaro M, Sala M, Savarino V, Risso D, Ghittoni G, Roselli P, Grazi GL, Nardo B, Ravaioli M, Pinna AD, Giampalma E, Golfieri R, Farinati Fabio, Giacomin Anna, Vanin Veronica, Sergio Adriana, Burra Patrizia, Cillo Umberto, Di Nolfo Annamaria, Del Poggio Paolo, Benvegnu Luisa, Zoli Marco, Borzio Franco, Giannini Edoardo, Caturelli Eugenio, Cazzagon Nora, Rapaccini Gian Ludovico, Trevisani Franco, for the Italian Liver Cancer (ITA.LI.CA) group [.., Andreone P, Bernardi M, Biselli M, Caraceni P, di Micoli A, Domenicali M, Magalotti D, Cappa FM, Santi V, Zambruni A, Balsamo C, Di Marco M, Vavassori E, Gilardoni L, Mattiello M, Alberti A, Gatta A, Gios M, Molaro M, Sala M, Savarino V, Risso D, Ghittoni G, Roselli P, Grazi GL, Nardo B, Ravaioli M, Pinna AD, Giampalma E, Golfieri R, and ]
- Subjects
Male ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,medicine.medical_treatment ,Liver transplantation ,Guideline ,Gastroenterology ,Internal medicine ,Carcinoma ,Medicine ,Humans ,guidelines ,neoplasms ,Selection (genetic algorithm) ,Aged ,Hepatology ,business.industry ,General surgery ,HEPATOCELLULAR CARCINOMA ,LIVER TRANSPLANTATION ,Guidelines ,Evidence-based approach ,Patient Selection ,Liver Neoplasms ,hepatocellular carcinoma ,evidence-based approach ,liver transplantation ,Middle Aged ,medicine.disease ,Prognosis ,digestive system diseases ,Liver Transplantation ,Neoplasm Proteins ,Clinical Practice ,Transplantation ,Treatment Outcome ,Italy ,Hepatocellular carcinoma ,Practice Guidelines as Topic ,Female ,Guideline Adherence ,alpha-Fetoproteins ,business ,Epidemiologic Methods - Abstract
INTRODUCTION: Hepatocellular carcinoma (HCC) is an established indication for liver transplantation (LT), but the selection criteria and priority are still debated. AIMS: To ascertain the number and features of patients with HCC who undergo transplantation in a Western country, the number of patients eligible for LT according to the American Association for the Study of Liver Diseases (AASLD) guidelines, the number of patients who actually undergo transplantation and whether adherence affects survival. METHODS: This is a retrospective analysis from a multicentre Italian database of 2042 cases of HCC, recruited prospectively and consecutively. Kaplan-Meier (log rank) and Cox multivariate analysis estimated survival. RESULTS: Patients who had undergone transplantation (50, 2.5%, with no change over time) had a median survival of 133 months, significantly influenced by the number of lesions and alpha-fetoprotein levels, which were found to be independent predictors of survival on multivariate analysis. Milan criteria were fulfilled in 68%, impacting on survival, whereas 48% fulfilled AASLD guidelines, without such an impact. Two hundred and twenty-eight (11%) patients were eligible for LT according to AASLD; in this group, alpha-fetoprotein levels and Child-Pugh class were independent predictors of survival. CONCLUSION: Among patients with HCC, those undergoing LT represent a small minority; even fewer (1%) are those who undergo transplantation according to AASLD guidelines, adherence to which only marginally affects survival. Overall, LT impact on HCC patients' treatment is very limited
- Published
- 2011
18. Hepatocellular carcinoma in patients with cryptogenic cirrhosis
- Author
-
Edoardo Giovanni Giannini, Elisa Marabotto, Vincenzo Savarino, Maria Anna di Nolfo, Paolo Del Poggio∥, Luisa Benvegnù, Fabio Farinati, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, Italian Liver Cancer Group [. . ., Cursaro C., Di Micoli A., Frigerio M., Cappa F. M., Santi V., Zambruni A., GRAZI, GIAN LUCA, Ravaioli M., Giampalma E., Di Marco M., Vavassori E., Gilardoni L., Mattiello M., Alberti A., Gatta A., Gios M., De Giorgio M., Gianni S., Rinaldi M., Roselli P., Ghittoni G., TREVISANI, FRANCO, ZOLI, MARCO, ANDREONE, PIETRO, BERNARDI, MAURO, CARACENI, PAOLO, DOMENICALI, MARCO, GRAMENZI, ANNAGIULIA, NARDO, BRUNO, GOLFIERI, RITA, Edoardo Giovanni Giannini, Elisa Marabotto, Vincenzo Savarino, Franco Trevisani, Maria Anna di Nolfo, Paolo Del Poggio∥, Luisa Benvegnù, Fabio Farinati, Marco Zoli, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, Italian Liver Cancer (ITALICA) Group [.., Andreone P., Bernardi M., Caraceni P., Cursaro C., Di Micoli A., Domenicali M., Gramenzi A., Frigerio M., Cappa F.M., Santi V., Zambruni A., Grazi G.L., Nardo B., Ravaioli M., Giampalma E., Golfieri R., Di Marco M., Vavassori E., Gilardoni L., Mattiello M., Alberti A., Gatta A., Gios M., De Giorgio M., Gianni S., Rinaldi M., Roselli P., Ghittoni G., and ]
- Subjects
Adult ,Liver Cirrhosis ,Male ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,HEPATOCELLULAR CARCINOMA ,CRYPTOGENIC CIRRHOSIS ,Hepatitis C virus ,medicine.disease_cause ,Gastroenterology ,Internal medicine ,medicine ,Carcinoma ,Humans ,Transaminases ,Aged ,Hepatitis, Chronic ,Hepatitis B virus ,Hepatitis ,Aged, 80 and over ,Hepatology ,business.industry ,Platelet Count ,Middle Aged ,medicine.disease ,digestive system diseases ,Cryptogenic cirrhosis ,Hepatocellular carcinoma ,Female ,Liver function ,business ,Liver cancer - Abstract
BACKGROUND & AIMS: Patients with cryptogenic cirrhosis (CC) can develop hepatocellular carcinoma (HCC), although the clinical characteristics of HCC in these patients have not been completely defined. We aimed to characterize the clinical features of patients diagnosed with HCC after CC during a 15-year period (1992-2006). METHODS: The clinical characteristics of 45 consecutive CC patients with HCC were analyzed, along with modality of diagnosis, tumor stage, treatment, survival, and causes of death. Data were compared with those of 426 consecutive patients with HCC and only hepatitis C virus (HCV) infection, diagnosed during the same period at the Italian Liver Cancer group centers. RESULTS: HCC patients with CC had similar impairments in liver function as patients with HCV infection (Child-Pugh class A: 53% vs 65%; P = .141). However, the HCC patients with CC had lower aminotransferase levels (P < .001) and higher platelet counts (P < .001). HCC was significantly less likely to be diagnosed during surveillance in CC patients (29% vs 64%; P < .0001). Patients with CC had a significantly greater prevalence of advanced HCC stage, according to Milano criteria (69% vs 41%; P < .0005), larger HCC size (4.9 vs 3.0 cm; P = .0001), lower amenability to any treatment (27% vs 42%; P = .036), and shorter survival times (P = .009, log-rank test) compared with HCV patients. Causes of death were similar in the 2 groups. CONCLUSIONS: Compared with HCV patients, HCC in CC patients often is diagnosed at an advanced stage, probably owing to lack of surveillance; this leads to limited treatment options and shorter survival times.
- Published
- 2009
19. Dimostrare è calcolare
- Author
-
Roselli, P
- Subjects
Settore MAT/04 - Matematiche Complementari - Published
- 2004
20. The Lebesgue integral immediately after calculus
- Author
-
Roselli, P and Willem, M
- Subjects
Settore MAT/05 - Published
- 2002
21. Efficacia, sicurezza e tollerabilità del trattamento a lungo termine con dosi ridotte giornaliere di soluzioni elettrolitiche bilanciate iso-osmolari contenenti PEG (PMF-100) nella stitichezza cronica funzionale
- Author
-
Corazziari, E, Badiali, D, Bazzocchi, G, DEL MONTE PR, Bassotti, Gabrio, Roselli, P, Mastropaolo, G, Lucà, Mg, Galeazzi, R, and Peruzzi, E.
- Published
- 1999
22. Use of polyethylene glycol solution in slow transit constipation
- Author
-
Bassotti, Gabrio, Fiorella, S, Roselli, P, and Modesto, R.
- Published
- 1999
23. Aspetti manometrici e clinici dei disturbi motori esofagei non specifici
- Author
-
Bassotti, Gabrio, Fiorella, S, and Roselli, P.
- Published
- 1999
24. Esofago a schiaccianoce e spasmo esofageo diffuso
- Author
-
Bassotti, Gabrio, Fiorella, S, Roselli, P, and Morelli, Antonio
- Published
- 1998
25. Ruolo della manometria nella dissinergia: principi tecnici, parametri e criteri di lettura
- Author
-
Bassotti, Gabrio, Calcara, C, Roselli, P, Fiorella, S, and Bassotti, S.
- Published
- 1997
26. Effects of octreotide on manometric variables in patients with neuropathic abnormalities of the small bowel
- Author
-
Bassotti, Gabrio, Germani, U, Calcara, C, Spinozzi, Fabrizio, Roselli, P, and Morelli, A.
- Published
- 1997
27. Studio manometrico esofageo nei parkinsoniani
- Author
-
Bassotti, Gabrio, Germani, U, Pagliaricci, S, Roselli, P, Calcara, C, Battaglia, E, and Morelli, Antonio
- Published
- 1996
28. Octreotide: utile nelle neuropatie intestinali?
- Author
-
Bassotti, Gabrio, Calcara, C, Germani, U, Roselli, P, Battaglia, E, and Morelli, Antonio
- Published
- 1996
29. Neurological assessment with validated tools in general ICU: multicenter, randomized, before and after, pragmatic study to evaluate the effectiveness of an e-learning platform for continuous medical education
- Author
-
Mistraletti, G, Umbrello, M, Anania, S, Andrighi, E, Di Carlo, A, Martinetti, F, Barello, S, Sabbatini, G, Formenti, P, Maraffi, T, Marrazzo, F, Palo, A, Bellani, G, Russo, R, Francesconi, S, Valdambrini, F, Cigada, M, Riccardi, F, Moja, E, Iapichino, G, Spanu, P, Cappello, G, Baglio, L, Sabatelli, B, Brenna, G, Astori, M, Villa, C, Placido, P, Gattinoni, L, Protti, A, Pagan, F, Berto, V, Sparacino, C, Roselli, P, Noé, E, Mauri, I, Poti, F, Ronzoni, G, Beck, E, Gaiotto, M, Radrizzani, D, Ferla, L, Giudici, R, Merlini, L, Pesenti, A, Rezoagli, E, La Bruna, A, Lucchini, A, Braschi, A, Niebel, T, Selvini, M, Cortesi, S, Quaini, A, Iotti, G, Contri, E, Sacchi, A, Scartezzini, A, Malagò, G, Furletti, F, Morandini, M, Mistraletti, G, Umbrello, M, Anania, S, Andrighi, E, Di Carlo, A, Martinetti, F, Barello, S, Sabbatini, G, Formenti, P, Maraffi, T, Marrazzo, F, Palo, A, Bellani, G, Russo, R, Francesconi, S, Valdambrini, F, Cigada, M, Riccardi, F, Moja, E, Iapichino, G, Spanu, P, Cappello, G, Baglio, L, Sabatelli, B, Brenna, G, Astori, M, Villa, C, Placido, P, Gattinoni, L, Protti, A, Pagan, F, Berto, V, Sparacino, C, Roselli, P, Noé, E, Mauri, I, Poti, F, Ronzoni, G, Beck, E, Gaiotto, M, Radrizzani, D, Ferla, L, Giudici, R, Merlini, L, Pesenti, A, Rezoagli, E, La Bruna, A, Lucchini, A, Braschi, A, Niebel, T, Selvini, M, Cortesi, S, Quaini, A, Iotti, G, Contri, E, Sacchi, A, Scartezzini, A, Malagò, G, Furletti, F, and Morandini, M
- Subjects
Adult ,Male ,medicine.medical_specialty ,Critical Care ,Sedation ,MEDLINE ,Settore M-PSI/06 - PSICOLOGIA DEL LAVORO E DELLE ORGANIZZAZIONI ,medical ,law.invention ,Education ,Education, Distance ,03 medical and health sciences ,Neurological assessment ,0302 clinical medicine ,Randomized controlled trial ,law ,medicine ,Humans ,distance-Education ,continuing-Neurophysiological monitoring-Pain-Delirium ,Pain Measurement ,Neurologic Examination ,Medical education ,030505 public health ,Distance ,Critically ill ,business.industry ,Delirium ,030208 emergency & critical care medicine ,Pain scale ,Continuing ,Middle Aged ,Education, distance-Education, medical, continuing-Neurophysiological monitoring-Pain-Delirium ,Intensive Care Units ,Anesthesiology and Pain Medicine ,Controlled Before-After Studies ,Assessment methods ,Physical therapy ,Education, Medical, Continuing ,Female ,Clinical Competence ,medicine.symptom ,0305 other medical science ,business ,Computer-Assisted Instruction - Abstract
BACKGROUND: International guidelines recommend systematic assessment of pain, agitation/sedation and delirium with validated scales for all ICU patients. However, these evaluations are often not done. We have created an e-learning training platform for the continuous medical education, and assessed its efficacy in increasing the use of validated tools by all medical and nursing staff of the participating ICUs during their daily practice. METHODS: Multicenter, randomized, before and after study. The eight participating centers were randomized in two groups, and received training at different times. The use of validated tools (Verbal Numeric Rating or Behavioral Pain Scale for pain; Richmond Agitation-Sedation Scale for agitation; Confusion Assessment Method for the ICU for delirium) was evaluated from clinical data recorded in medical charts during a week, with follow-up up to six months after the training. All the operators were invited to complete a questionnaire, at baseline and after the training. RESULTS : Among the 374 nurses and physicians involved, 140 (37.4%) completed at least one of the three courses. The assessment of pain (38.1 vs. 92.9%, P
30. Triple Resonance on the CH3OH Laser: Asymmetry Splitting and New Lines
- Author
-
Inguscio, M., Ioli, N., Moretti, A., Moruzzi, Giovanni, Roselli, P., and Strumia, F.
- Published
- 1983
31. Triple Resonance in CH3OH
- Author
-
Ioli, N., Moretti, A., Moruzzi, Giovanni, Roselli, P., and Strumia, F.
- Published
- 1985
32. Observations on the natural history, diagnosis and therapy of the HCV hepatitis | OSSERVAZIONI SULLA STORIA NATURALE, LA DIAGNOSTICA E LA TERAPIA DELL'EPATITE DA HCV
- Author
-
Pizzigallo, E., Colozzi, A., Vecchiet, J., Roselli, P., Barberio, A., Musiani, P., Angelucci, D., Mencarini, P., and Enrica TAMBURRINI
33. Toward a New Probabilistic Framework to Score and Merge Ground‐Motion Prediction Equations: The Case of the Italian Region
- Author
-
P. Roselli, Warner Marzocchi, Licia Faenza, Roselli, P., Marzocchi, W., and Faenza, L.
- Subjects
Focal mechanism ,Peak ground acceleration ,010504 meteorology & atmospheric sciences ,Ensemble forecasting ,Computer science ,Probabilistic logic ,Inversion (meteorology) ,Regression analysis ,010502 geochemistry & geophysics ,computer.software_genre ,01 natural sciences ,Geophysics ,Geochemistry and Petrology ,Data mining ,Probabilistic framework ,Merge (version control) ,computer ,0105 earth and related environmental sciences - Abstract
The ground‐motion prediction equation (GMPE) is a basic component for probabilistic seismic‐hazard analysis. There is a wide variety of GMPEs that are usually obtained by means of inversion techniques of datasets containing ground motions recorded at different stations. However, to date there is not yet a commonly accepted procedure to select the best GMPE for a specific case; usually, a set of GMPEs is implemented (more or less arbitrarily) in a logic‐tree structure, in which each GMPE is weighted by experts, mostly according to gut feeling. Here, we discuss a general probabilistic framework to numerically score and weight GMPEs, highlighting features, limitations, and approximations; finally, we put forward a numerical procedure to score GMPEs, taking into account their forecasting performances, and to merge them through an ensemble modeling. Then, we apply the procedure to the Italian territory; in addition to illustrating how the procedure works, we investigate other relevant aspects (such as the importance of the focal mechanism) of the GMPEs to different site conditions. Online Material: Figures showing regression analysis for peak ground acceleration (PGA) values and location map, and earthquake catalog and summary table of parameters corresponding to each ground‐motion prediction equation (GMPE) implemented.
- Published
- 2016
34. Earthquake focal mechanism forecasting in Italy for PSHA purposes
- Author
-
Maria Teresa Mariucci, P. Roselli, Warner Marzocchi, Paola Montone, Roselli, P., Marzocchi, W., Mariucci, M. T., and Montone, P.
- Subjects
Focal mechanism ,Geophysics ,010504 meteorology & atmospheric sciences ,Geochemistry and Petrology ,Statistical seismology ,010502 geochemistry & geophysics ,01 natural sciences ,Geology ,Seismology ,0105 earth and related environmental sciences - Abstract
In this paper, we put forward a procedure that aims to forecast focal mechanism of future earthquakes. One of the primary uses of such forecasts is in probabilistic seismic hazard analysis (PSHA); in fact, aiming at reducing the epistemic uncertainty, most of the newer ground motion prediction equations consider, besides the seismicity rates, the forecast of the focal mechanism of the next large earthquakes as input data. The data set used to this purpose is relative to focal mechanisms taken from the latest stress map release for Italy containing 392 well-constrained solutions of events, from 1908 to 2015, with Mw ≥ 4 and depths from 0 down to 40 km. The data set considers polarity focal mechanism solutions until to 1975 (23 events), whereas for 1976-2015, it takes into account only the Centroid Moment Tensor (CMT)-like earthquake focal solutions for data homogeneity. The forecasting model is rooted in the Total Weighted Moment Tensor concept that weighs information of past focal mechanisms evenly distributed in space, according to their distance from the spatial cells and magnitude. Specifically, for each cell of a regular 0.1° × 0.1° spatial grid, the model estimates the probability to observe a normal, reverse, or strike-slip fault plane solution for the next large earthquakes, the expected moment tensor and the related maximum horizontal stress orientation. These results will be available for the new PSHA model for Italy under development. Finally, to evaluate the reliability of the forecasts, we test them with an independent data set that consists of some of the strongest earthquakes with Mw ≥ 3.9 occurred during 2016 in different Italian tectonic provinces. © The Authors 2017. Published by Oxford University Press on behalf of The Royal Astronomical Society.
- Published
- 2018
35. A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma
- Author
-
Cabibbo, Giuseppe, Petta, Salvatore, Barbã ra, Marco, Missale, Gabriele, Virdone, Roberto, Caturelli, Eugenio, Piscaglia, Fabio, Morisco, Filomena, Colecchia, Antonio, Farinati, Fabio, Giannini, Edoardo, Trevisani, Franco, Craxã¬, Antonio, Colombo, Massimo, Cammã , Calogero, Bucci, Laura, Zoli, Marco, Garuti, Francesca, Lenzi, Barbara, Biselli, Maurizio, Caraceni, Paolo, Cucchetti, Alessandro, Gramenzi, Annagiulia, Granito, Alessandro, Magalotti, Donatella, Serra, Carla, Negrini, Giulia, Napoli, Lucia, Salvatore, Veronica, Benevento, Francesca, Benvegnã¹, Luisa, Gazzola, Alessia, Murer, Francesca, Pozzan, Caterina, Vanin, Veronica, Moscatelli, Alessandro, Pellegatta, Gaia, Picciotto, Antonino, Savarino, Vincenzo, Ciccarese, Francesca, Del Poggio, Paolo, Olmi, Stefano, de Matthaeis, Nicoletta, Balsamo, Mariella Di Marco Claudia, Vavassori, Elena, Roselli, Paola, Dell’Isola, Serena, Ialungo, Anna Maria, Rastrelli, Elena, Attardo, Simona, Rossi, Margherita, Costantino, Andrea, Affronti, Andrea, Affronti, Marco, Mascari, Marta, Felder, Martina, Mega, Andrea, Gasbarrini, Antonio, Pompili, Maurizio, Rinninella, Emanuele, Sacco, Rodolfo, Mismas, Valeria, Foschi, Francesco Giuseppe, Dall’Aglio, Anna Chiara, Feletti, Valentina, Lanzi, Arianna, Cappa, Federica Mirici, Neri, Elga, Stefanini, Giuseppe Francesco, Tamberi, Stefano, Olivani, Andrea, Biasini, Elisabetta, Nardone, Gerardo, Guarino, Maria, Svegliati-Baroni, Gialuca, Ortolani, Alessio, Masotto, Alberto, Marchetti, Fabiana, Valerio, Matteo, Marra, Fabio, Aburas, Sami, Inghilesi, Andrea L, Cappelli, Alberta, Golfieri, Rita, Mosconi, MARIA CRISTINA, Renzulli, Matteo, Coccoli, Piero, Zamparelli, Marco Sanduzzi, Benvegnu', Luisa, Cabibbo, Giuseppe, Petta, Salvatore, Barbàra, Marco, Missale, Gabriele, Virdone, Roberto, Caturelli, Eugenio, Piscaglia, Fabio, Morisco, Filomena, Colecchia, Antonio, Farinati, Fabio, Giannini, Edoardo, Trevisani, Franco, Craxì, Antonio, Colombo, Massimo, Cammà, Calogero, Nardone, GERARDO ANTONIO PIO, Cabibbo, G., Petta, S., Barbara, M., Missale, G., Virdone, R., Caturelli, E., Piscaglia, F., Morisco, F., Colecchia, A., Farinati, F., Giannini, E., Trevisani, F., Craxi, A., Colombo, M., Camma, C., Bucci, L., Zoli, M., Garuti, F., Lenzi, B., Biselli, M., Caraceni, P., Cucchetti, A., Gramenzi, A., Granito, A., Magalotti, D., Serra, C., Negrini, G., Napoli, L., Salvatore, V., Benevento, F., Benvegnu, L., Gazzola, A., Murer, F., Pozzan, C., Vanin, V., Moscatelli, A., Pellegatta, G., Picciotto, A., Savarino, V., Ciccarese, F., Del Poggio, P., Olmi, S., de Matthaeis, N., Balsamo, M. D. M. C., Vavassori, E., Roselli, P., Dell'Isola, S., Ialungo, A. M., Rastrelli, E., Attardo, S., Rossi, M., Costantino, A., Affronti, A., Affronti, M., Mascari, M., Felder, M., Mega, A., Gasbarrini, A., Pompili, M., Rinninella, E., Sacco, R., Mismas, V., Foschi, F. G., Dall'Aglio, A. C., Feletti, V., Lanzi, A., Cappa, F. M., Neri, E., Stefanini, G. F., Tamberi, S., Olivani, A., Biasini, E., Nardone, G., Guarino, M., Svegliati-Baroni, G., Ortolani, A., Masotto, A., Marchetti, F., Valerio, M., Marra, F., Aburas, S., Inghilesi, A. L., Cappelli, A., Golfieri, R., Mosconi, C., Renzulli, M., Coccoli, P., Zamparelli, M. S., Barbã ra, Marco, Craxã¬, Antonio, Cammã , Calogero, Bucci, Laura, Zoli, Marco, Garuti, Francesca, Lenzi, Barbara, Biselli, Maurizio, Caraceni, Paolo, Cucchetti, Alessandro, Gramenzi, Annagiulia, Granito, Alessandro, Magalotti, Donatella, Serra, Carla, Negrini, Giulia, Napoli, Lucia, Salvatore, Veronica, Benevento, Francesca, Benvegnã¹, Luisa, Gazzola, Alessia, Murer, Francesca, Pozzan, Caterina, Vanin, Veronica, Moscatelli, Alessandro, Pellegatta, Gaia, Picciotto, Antonino, Savarino, Vincenzo, Ciccarese, Francesca, Del Poggio, Paolo, Olmi, Stefano, de Matthaeis, Nicoletta, Balsamo, Mariella Di Marco Claudia, Vavassori, Elena, Roselli, Paola, Dellâ isola, Serena, Ialungo, Anna Maria, Rastrelli, Elena, Attardo, Simona, Rossi, Margherita, Costantino, Andrea, Affronti, Andrea, Affronti, Marco, Mascari, Marta, Felder, Martina, Mega, Andrea, Gasbarrini, Antonio, Pompili, Maurizio, Rinninella, Emanuele, Sacco, Rodolfo, Mismas, Valeria, Foschi, Francesco Giuseppe, Dallâ aglio, Anna Chiara, Feletti, Valentina, Lanzi, Arianna, Federica Mirici, Cappa, Neri, Elga, Stefanini, Giuseppe Francesco, Tamberi, Stefano, Olivani, Andrea, Biasini, Elisabetta, Nardone, Gerardo, Guarino, Maria, Svegliati-Baroni, Gialuca, Ortolani, Alessio, Masotto, Alberto, Marchetti, Fabiana, Valerio, Matteo, Marra, Fabio, Aburas, Sami, Inghilesi, Andrea L, Cappelli, Alberta, Golfieri, Rita, Mosconi, Cristina, Renzulli, Matteo, Coccoli, Piero, Zamparelli, Marco Sanduzzi, Camma', C., Benvegnã¹, L., Balsamo, M., Dell’Isola, S., Ialungo, A., Foschi, F., Dall’Aglio, A., Cappa, F., Stefanini, G., Inghilesi, A., and Zamparelli, M.
- Subjects
Oncology ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,recurrence ,Hepatitis C virus ,medicine.medical_treatment ,medicine.disease_cause ,survival ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,medicine ,Adjuvant therapy ,hepatocellular carcinoma ,prognosis ,recurrences ,Humans ,Survival analysis ,Hepatology ,business.industry ,Liver Neoplasms ,medicine.disease ,Hepatitis C ,030220 oncology & carcinogenesis ,Meta-analysis ,Hepatocellular carcinoma ,030211 gastroenterology & hepatology ,Neoplasm Recurrence, Local ,business ,Adjuvant ,prognosi - Abstract
Background & Aims: Determining risk for recurrence or survival after curative resection or ablation in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) is important for stratifying patients according to expected outcomes in future studies of adjuvant therapy in the era of direct-acting antivirals (DAAs). The aims of this meta-analysis were to estimate the recurrence and survival probabilities of HCV-related early HCC following complete response after potentially curative treatment and to identify predictors of recurrence and survival. Methods: Studies reporting time-dependent outcomes (HCC recurrence or death) after potentially curative treatment of HCV-related early HCC were identified in MEDLINE through May 2016. Data on patient populations and outcomes were extracted from each study by three independent observers and combined using a distribution-free summary survival curve. Primary outcomes were actuarial probabilities of recurrence and survival. Results: Eleven studies met the inclusion criteria. Pooled estimates of actuarial recurrence rates were 7.4% at 6months and 47.0% at 2years. Pooled estimates of actuarial survival rates were 79.8% at 3years and 58.6% at 5years. Heterogeneity among studies was highly significant for all outcomes. By univariate meta-regression analyses, lower serum albumin, randomized controlled trial study design and follow-up were independently associated with higher recurrence risk, whereas tumour size and alpha-foetoprotein levels were associated with higher mortality. Conclusions: This meta-analysis showed that recurrence risk and survival are extremely variable in patients with successfully treated HCV-related HCC, providing a useful benchmark for indirect comparisons of the benefits of DAAs and for a correct design of randomized controlled trials in the adjuvant setting.
- Published
- 2017
36. Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
- Author
-
Petta, S., Cabibbo, G., Barbara, M., Attardo, S., Bucci, L., Farinati, F., Giannini, E. G., Tovoli, F., Ciccarese, F., Rapaccini, Gian Ludovico, Di Marco, M., Caturelli, E., Zoli, M., Borzio, F., Sacco, R., Virdone, R., Marra, F., Felder, M., Morisco, F., Benvegnù, L., Gasbarrini, Antonio, Svegliati-Baroni, G., Foschi, F. G., Olivani, A., Masotto, A., Nardone, G., Colecchia, A., Persico, M., Boccaccio, V., Craxì, A., Bruno, S., Trevisani, F., Cammà, C, Biselli, Maurizio, Caraceni, Paolo, Cucchetti, Alessandro, Domenicali, Marco, Piscaglia, Fabio, Gramenzi, Annagiulia, Granito, Alessandro, Magalotti, Donatella, Serra, Carla, Negrini, Giulia, Napoli, L., Napoli, Lucia, Salvatore, Veronica, Benevento, Francesca, Gazzola, Alessia, Murer, Francesca, Pozzan, Caterina, Vanin, Veronica, Moscatelli, Alessandro, Pellegatta, Gaia, Picciotto, Antonino, Savarino, Vincenzo, Delpoggio, Paolo, Olmi, Stefano, De Matthaeis, Nicoletta, Balsamo, Claudia, Vavassori, Elena, Roselli, Paola, Dell’Isola, Serena, Ialungo, Anna Maria, Rastrelli, Elena, Rini, Francesca, Costantino, Andrea, Affronti, Andrea, Affronti, Marco, Mascari, Marta, Mega, Andrea, Pompili, Maurizio, Rinninella, Emanuele, Mismas, Valeria, Dall’Aglio, Anna Chiara, Feletti, Valentina, Lanzi, Arianna, Cappa, Federica Mirici, Neri, Elga, Stefanini, Giuseppe Francesco, Tamberi, Stefano, Biasini, Elisabetta, Missale, Gabriele, Guarino, Maria, Ortolani, Alessio, Chiaramonte, Maria, Marchetti, Fabiana, Valerio, Matteo, Aburas, Sami, Inghilesi, Andrea L., Cappelli, Alberta, Golfieri, Rita, Mosconi, Cristina, Renzulli, Matteo, Coccoli, Piero, Zamparelli, Marco Sanduzzi, Petta, Salvatore, Cabibbo, Giuseppe, Barbara, Marco, Attardo, Simona, Bucci, Laura, Farinati, Fabio, Giannini, Edoardo G., Tovoli, Francesco, Ciccarese, Francesca, Rapaccini, Gian Lodovico, Dimarco, Maria, Caturelli, Eugenio, Zoli, Marco, Borzio, Franco, Sacco, Rodolfo, Virdone, Roberto, Marra, Fabio, Felder, Martina, Morisco, Filomena, Benvegnù, Luisa, Svegliati-Baroni, Gianluca, Foschi, Francesco Giuseppe, Olivani, Andrea, Masotto, Alberto, Nardone, Gerardo, Colecchia, Antonio, Persico, Marcello, Boccaccio, Vincenzo, Craxì, Antonio, Bruno, Savino, Trevisani, Franco, Cammà, Calogero, Petta, S, Cabibbo, G, Barbara, M, Attardo, S, Bucci, L, Farinati, F, Giannini, E. G, Tovoli, F, Ciccarese, F, Rapaccini, G. L, Di Marco, M, Caturelli, E, Zoli, M, Borzio, F, Sacco, R, Virdone, R, Marra, F, Felder, M, Morisco, Filomena, Benvegnù, L, Gasbarrini, A, Svegliati Baroni, G, Foschi, F. G, Olivani, A, Masotto, A, Nardone, GERARDO ANTONIO PIO, Colecchia, A, Persico, M, Boccaccio, V, Craxì, A, Bruno, S, Trevisani, F, Cammà, C., DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE, DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE, Facolta' di MEDICINA e CHIRURGIA, Da definire, AREA MIN. 06 - Scienze mediche, Petta, S., Cabibbo, G., Barbara, M., Attardo, S., Bucci, L., Farinati, F., Giannini, E., Tovoli, F., Ciccarese, F., Rapaccini, G., Di Marco, M., Caturelli, E., Zoli, M., Borzio, F., Sacco, R., Virdone, R., Marra, F., Felder, M., Morisco, F., Benvegnã¹, L., Gasbarrini, A., Svegliati-Baroni, G., Foschi, F., Olivani, A., Masotto, A., Nardone, G., Colecchia, A., Persico, M., Boccaccio, V., Craxi, A., Bruno, S., Trevisani, F., Camma', C., Biselli, M., Caraceni, P., Cucchetti, A., Domenicali, M., Piscaglia, F., Gramenzi, A., Granito, A., Magalotti, D., Serra, C., Negrini, G., Napoli, L., Salvatore, V., Benevento, F., Gazzola, A., Murer, F., Pozzan, C., Vanin, V., Moscatelli, A., Pellegatta, G., Picciotto, A., Savarino, V., Delpoggio, P., Olmi, S., Dematthaeis, N., Balsamo, C., Vavassori, E., Roselli, P., Dell’Isola, S., Ialungo, A., Rastrelli, E., Rini, F., Costantino, A., Affronti, A., Affronti, M., Mascari, M., Mega, A., Pompili, M., Rinninella, E., Mismas, V., Dall’Aglio, A., Feletti, V., Lanzi, A., Cappa, F., Neri, E., Stefanini, G., Tamberi, S., Biasini, E., Missale, G., Guarino, M., Ortolani, A., Chiaramonte, M., Marchetti, F., Valerio, M., Aburas, S., Inghilesi, A., Cappelli, A., Golfieri, R., Mosconi, C., Renzulli, M., Coccoli, P., Zamparelli, M., Giannini, E.G., Rapaccini, G.L., Benvegnù, L., Foschi, F.G., Craxì, A., Cammà, C, the Italian Liver Cancer (ITALICA) Group [, Maurizio Biselli, Paolo Caraceni, Alessandro Cucchetti, Marco Domenicali, Fabio Piscaglia, Annagiulia Gramenzi, Alessandro Granito, Donatella Magalotti, Carla Serra, Giulia Negrini, Lucia Napoli, Veronica Salvatore, Francesca Benevento, ], Giannini, E. G., Rapaccini, G. L., Benvegnu, L., Foschi, F. G., Camma, C., Dell'Isola, S., Ialungo, A. M., Dall'Aglio, A. C., Cappa, F. M., Stefanini, G. F., Inghilesi, A. L., and Zamparelli, M. S.
- Subjects
Liver Cirrhosis ,Male ,Cirrhosis ,Databases, Factual ,Gastroenterology ,HCV-infected cirrhotic patients ,hepatocellular carcinoma ,HCC ,sustained viral eradication ,SVR ,interferon ,0302 clinical medicine ,Retrospective Studie ,Pharmacology (medical) ,Prospective Studies ,Prospective cohort study ,Aged, 80 and over ,Liver Neoplasms ,virus diseases ,Hepatitis C ,Middle Aged ,Liver Neoplasm ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Catheter Ablation ,Interferon ,030211 gastroenterology & hepatology ,Female ,Liver cancer ,Human ,Adult ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Liver Cirrhosi ,Antiviral Agents ,Follow-Up Studie ,03 medical and health sciences ,Internal medicine ,medicine ,Carcinoma ,Early Hepatocellular Carcinoma ,Humans ,Aged ,Retrospective Studies ,Antiviral Agent ,Hepatology ,business.industry ,Settore MED/09 - MEDICINA INTERNA ,Retrospective cohort study ,medicine.disease ,digestive system diseases ,Surgery ,Prospective Studie ,Interferons ,Neoplasm Recurrence, Local ,business ,Follow-Up Studies - Abstract
none 48 no Background: In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma (HCC), the time to HCC recurrence and the effects of sustained viral eradication (SVR) by interferon (IFN)-based or IFN-free regimens on HCC recurrence remain unclear. Aim: To perform an indirect comparison of time to recurrence (TTR) in patients with successfully treated early HCC and active HCV infection with those of patients with SVR by IFN-based and by IFN-free regimens. Methods: We evaluated 443 patients with HCV-related cirrhosis and Barcelona Clinic Liver Cancer Stage A/0 HCC who had a complete radiological response after curative resection or ablation. Active HCV infection was present in 328, selected from the Italian Liver Cancer group cohort; 58 patients had SVR achieved by IFN-free regimens after HCC cure, and 57 patients had SVR achieved by IFN-based regimens after HCC cure. Individual data of patients in the last two groups were extracted from available publications. Results: TTR by Kaplan–Meier curve was significantly lower in patients with active HCV infection compared with those with SVR both by IFN-free (P = 0.02) and by IFN-based (P < 0.001) treatments. TTR was similar in patients with SVR by IFN-free or by IFN-based (P = 0.49) strategies. Conclusion: In HCV-infected, successfully treated patients with early HCC, SVR obtained by IFN-based or IFN-free regimens significantly reduce tumour recurrence without differences related to the anti-viral strategy used. Petta, S.; Cabibbo, G.; Barbara, M.; Attardo, S.; Bucci, L.; Farinati, F.; Giannini, E.G.; Tovoli, F.; Ciccarese, F.; Rapaccini, G.L.; Di Marco, M.; Caturelli, E.; Zoli, M.; Borzio, F.; Sacco, R.; Virdone, R.; Marra, F.; Felder, M.; Morisco, F.; Benvegnù, L.; Gasbarrini, A.; Svegliati-Baroni, G.; Foschi, F.G.; Olivani, A.; Masotto, A.; Nardone, G.; Colecchia, A.; Persico, M.; Boccaccio, V.; Craxì, A.; Bruno, S.; Trevisani, F.; Cammà, C; the Italian Liver Cancer (ITALICA) Group [ ; Maurizio Biselli; Paolo Caraceni; Alessandro Cucchetti; Marco Domenicali; Fabio Piscaglia; Annagiulia Gramenzi; Alessandro Granito; Donatella Magalotti; Carla Serra; Giulia Negrini; Lucia Napoli; Veronica Salvatore; Francesca Benevento;] Petta, S.; Cabibbo, G.; Barbara, M.; Attardo, S.; Bucci, L.; Farinati, F.; Giannini, E.G.; Tovoli, F.; Ciccarese, F.; Rapaccini, G.L.; Di Marco, M.; Caturelli, E.; Zoli, M.; Borzio, F.; Sacco, R.; Virdone, R.; Marra, F.; Felder, M.; Morisco, F.; Benvegnù, L.; Gasbarrini, A.; Svegliati-Baroni, G.; Foschi, F.G.; Olivani, A.; Masotto, A.; Nardone, G.; Colecchia, A.; Persico, M.; Boccaccio, V.; Craxì, A.; Bruno, S.; Trevisani, F.; Cammà, C; the Italian Liver Cancer (ITALICA) Group [ ; Maurizio Biselli; Paolo Caraceni; Alessandro Cucchetti; Marco Domenicali; Fabio Piscaglia; Annagiulia Gramenzi; Alessandro Granito; Donatella Magalotti; Carla Serra; Giulia Negrini; Lucia Napoli; Veronica Salvatore; Francesca Benevento;]
- Published
- 2017
37. Years of life that could be saved from prevention of hepatocellular carcinoma
- Author
-
Andrea Costantino, Marcello Maida, Fabio Farinati, Laura Schiadà, Stefano Tamberi, Alessandro Moscatelli, Elena Rastrelli, Maria Chiaramonte, Paolo Poggio, Gianluca Svegliati Baroni, Matteo Renzulli, Fabio Piscaglia, Filomena Morisco, Paola Roselli, Roberto Virdone, Anna Maria Lalungo, Matteo Ravaioli, E.G. Giannini, Anna Chiara Dall’Aglio, Antonio Daniele Pinna, Elena Vavassori, Fabiana Marchetti, Eugenio Caturelli, Marco Domenicali, Calogero Cammà, Giulia Bosco, Carla Serra, Claudia Balsamo, Donatella Magalotti, Gian Ludovico Rapaccini, Valeria Mismas, S. Gemini, Stefano Olmi, Alberto Masotto, V. Feletti, Francesca Murer, Gaia Pellegatta, Maria Rosa Barcellona, A. Gazzola, Andrea Mega, Luigi Bolondi, Paolo Caraceni, Laura Bucci, Rita Golfieri, Annagiulia Gramenzi, Francesca Ciccarese, Rodolfo Sacco, Cristina Mosconi, Franco Borzio, Emanuele Rinninella, M. Di Marco, Alberta Cappelli, Marco Zoli, V. Vanin, Luisa Benvegnù, Mauro Bernardi, Emanuela Porro, Matteo Valerio, A. Pecorelli, Antonino Picciotto, Federica Mirici Cappa, Martina Felder, Elisabetta Biasini, Antonio Gasbarrini, Maurizio Biselli, Alessandro Cucchetti, Gabriele Missale, L. Venerandi, Serena Dell'Isola, Franco Trevisani, Elga Neri, Vincenzo Savarino, Maria Guarino, C. Pozzan, Giuseppe Cabibbo, F.G. Foschi, Giuseppe Francesco Stefanini, Arianna Lanzi, Andrea Affronti, Cucchetti, A, Trevisani, F, Bucci, L, Ravaioli, M, Farinati, F, Giannini, E. G, Ciccarese, F, Piscaglia, F, Rapaccini, G. L, Di Marco, M, Caturelli, E, Zoli, M, Borzio, F, Sacco, R, Maida, M, Felder, M, Morisco, Filomena, Gasbarrini, A, Gemini, S, Foschi, F. G, Missale, G, Masotto, A, Affronti, A, Bernardi, M, Pinna, A. D., Giannini, Eg, Rapaccini, Gl, Morisco, F, Foschi, Fg, Pinna, AD, Italian Liver Cancer (ITA.LI.CA.) Group, Bolondi, L, Biselli, M, Caraceni, P, Domenicali, M, Gramenzi, A., Cucchetti, A., Trevisani, F., Bucci, L., Ravaioli, M., Farinati, F., Giannini, E. G., Ciccarese, F., Piscaglia, F., Rapaccini, G. L., Di Marco, M., Caturelli, E., Zoli, M., Borzio, F., Sacco, R., Maida, M., Felder, M., Morisco, F., Gasbarrini, A., Gemini, S., Foschi, F. G., Missale, G., Masotto, A., Affronti, A., Bernardi, M., Bolondi, L., Biselli, M., Caraceni, P., Domenicali, M., Magalotti, D., Pecorelli, A., Serra, C., Venerandi, L., Gazzola, A., Murer, F., Pozzan, C., Vanin, V., Del Poggio, P., Olmi, S., Balsamo, C., Vavassori, E., Benvegnu, L., Cappelli, A., Golfieri, R., Mosconi, C., Renzulli, M., Bosco, G., Roselli, P., Dell'Isola, S., Lalungo, A. M., Rastrelli, E., Moscatelli, A., Pellegatta, G., Picciotto, A., Savarino, V., Barcellona, M. R., Camma, C., Cabibbo, G., Costantino, A., Virdone, R., Mega, A., Rinninella, E., Mismas, V., Dall'Aglio, A. C., Feletti, V., Lanzi, A., Cappa, F. M., Neri, E., Stefanini, G. F., Tamberi, S., Biasini, E., Porro, E., Guarino, M., Baroni, G. S., Schiada, L., Chiaramonte, M., Marchetti, F., and Valerio, M.
- Subjects
Registrie ,Male ,Pediatrics ,Databases, Factual ,Hepatocellular carcinoma ,0302 clinical medicine ,prevention ,80 and over ,Secondary Prevention ,Pharmacology (medical) ,Prospective Studies ,Registries ,Young adult ,Prospective cohort study ,Secondary prevention ,Aged, 80 and over ,education.field_of_study ,Liver Neoplasms ,Gastroenterology ,Disease Management ,Middle Aged ,Primary Prevention ,diagnosi ,Italy ,Liver Neoplasm ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Female ,Human ,Adult ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Adolescent ,Population ,life expentancy ,Milan criteria ,03 medical and health sciences ,Databases ,Young Adult ,Life Expectancy ,medicine ,Humans ,Aged ,education ,Factual ,Hepatology ,business.industry ,Carcinoma ,Settore MED/09 - MEDICINA INTERNA ,Hepatocellular ,medicine.disease ,Surgery ,Prospective Studie ,Years of potential life lost ,Life expectancy ,business - Abstract
Summary Background Hepatocellular carcinoma (HCC) causes premature death and loss of life expectancy worldwide. Its primary and secondary prevention can result in a significant number of years of life saved. Aim To assess how many years of life are lost after HCC diagnosis. Methods Data from 5346 patients with first HCC diagnosis were used to estimate lifespan and number of years of life lost after tumour onset, using a semi-parametric extrapolation having as reference an age-, sex- and year-of-onset-matched population derived from national life tables. Results Between 1986 and 2014, HCC lead to an average of 11.5 years-of-life lost for each patient. The youngest age-quartile group (18–61 years) had the highest number of years-of-life lost, representing approximately 41% of the overall benefit obtainable from prevention. Advancements in HCC management have progressively reduced the number of years-of-life lost from 12.6 years in 1986–1999, to 10.7 in 2000–2006 and 7.4 years in 2007–2014. Currently, an HCC diagnosis when a single tumour
- Published
- 2016
38. Assessing ‘alarm-based CN’ earthquake predictions in Italy
- Author
-
Warner Marzocchi, Matteo Taroni, P. Roselli, Taroni, M., Marzocchi, W., and Roselli, P.
- Subjects
010504 meteorology & atmospheric sciences ,Operations research ,Computer science ,Earthquake prediction ,lcsh:QC801-809 ,lcsh:QC851-999 ,010502 geochemistry & geophysics ,computer.software_genre ,01 natural sciences ,ALARM ,lcsh:Geophysics. Cosmic physics ,Geophysics ,Statistical analysis ,Quantitative assessment ,Earthquake interactions and probability ,lcsh:Meteorology. Climatology ,Data mining ,Predictability ,computer ,0105 earth and related environmental sciences - Abstract
The quantitative assessment of the performance of earthquake prediction and/or forecast models is essential for evaluating their applicability for risk reduction purposes. Here we assess the earthquake prediction performance of the CN model applied to the Italian territory. This model has been widely publicized in Italian news media, but a careful assessment of its prediction performance is still lacking. In this paper we evaluate the results obtained so far from the CN algorithm applied to the Italian territory, by adopting widely used testing procedures and under development in the Collaboratory for the Study of Earthquake Predictability (CSEP) network. Our results show that the CN prediction performance is comparable to the prediction performance of the stationary Poisson model, that is, CN predictions do not add more to what may be expected from random chance. © 2016 by the Istituto Nazionale di Geofisica e Vulcanologia. All rights reserved.
- Published
- 2016
39. The 2009 L'Aquila (central Italy) MW6.3 earthquake: Main shock and aftershocks
- Author
-
Claudio Chiarabba, Licia Faenza, Davide Piccinini, P. De Gori, Paola Baccheschi, Alessandro Marchetti, Marco Cattaneo, Irene Bianchi, D. Seccia, Francesco Pio Lucente, N. Piana Agostinetti, Alessandro Amato, Milena Moretti, Aladino Govoni, Francesco Mariano Mele, Mario Anselmi, M. Di Bona, Luisa Valoroso, Lucia Margheriti, Gianpaolo Cecere, Marina Pastori, Maria Grazia Ciaccio, Alberto Michelini, R. Di Stefano, P. Roselli, Lauro Chiaraluce, G. De Luca, Luigi Improta, Giancarlo Monachesi, Chiarabba, C, Amato, A, Anselmi, M, Baccheschi, P, Bianchi, I, Cattaneo, M, Cecere, G, Chiaraluce, L, Ciaccio, M, De Gori, P, De Luca, G, Di Bona, M, Di Stefano, R, Faenza, L, Govoni, A, Improta, L, Lucente, F, Marchetti, A, Margheriti, L, Mele, F, Michelini, A, Monachesi, G, Moretti, M, Pastori, M, Piana Agostinetti, N, Piccinini, D, Roselli, P, Seccia, D, and Valoroso, L
- Subjects
Seismic gap ,L aquila ,2009 L' Aquila earthquake, seismic sequence ,geography ,geography.geographical_feature_category ,Seismotectonics ,Induced seismicity ,Fault (geology) ,Shock (mechanics) ,Geophysics ,General Earth and Planetary Sciences ,Normal fault ,Aftershock ,Geology ,Seismology - Abstract
A Mw 6.3 earthquake struck on April 6, 2009 the Abruzzi region (central Italy) producing vast damage in the L'Aquila town and surroundings. In this paper we present the location and geometry of the fault system as obtained by the analysis of main shock and aftershocks recorded by permanent and temporary networks. The distribution of aftershocks, 712 selected events with ML > 2.3 and 20 with ML > 4.0, defines a complex, 40 km long, NW trending extensional structure. The main shock fault segment extends for 15 -18 km and dips at 45° to the SW, between 10 and 2 km depth. The extent of aftershocks coincides with the surface trace of the Paganica fault, a poorly known normal fault that, after the event, has been quoted to accommodate the extension of the area. We observe a migration of seismicity to the north on an echelon fault that can rupture in future large earthquakes. Copyright 2009 by the American Geophysical Union.
- Published
- 2009
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.